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1. INTRODUCTION 
  The Siddha system of medicine is one of the ancient systems contemporaneous with 
those of the submerged lands, Egyptian, Chinese and Grecian medicine. The unique nature of 
this system is continuous service to humanity for more than 5000 years in combating  disease 
and in maintaining its physical , mental and moral health. 
 Siddha system was developed by Siddhars. Siddhars are super human being. 
According to them physical body plays an important role in our life. It becomes our duty to 
keep it pure and perfect by regulating energy forces exiting in every individual, supplying 
necessary fuel to achieve proper balance, which is health and avoid imbalance which is 
illness. 
 The future of human society depends on the ability of children to achieve their 
optimal physical growth and psychological development. Early childhood development is 
considered to be most important phase in child‟s life which determine the quality of health 
well being, learning and behaviour across the life span, particularly during  toddler stage .It is 
the time between infancy and childhood  where a child learns and grows in many ways. It is a 
period of great opportunity but also easily prone to many disease, So proper child care should 
be taken. 
Kuzhanthai Maruthuvam is one among the treasures of siddha system exclusively 
dealing with disease which affects children. It is the collection of abundant medicine that 
pacifies the deranged humor paving way for healthy childhood thus laying a concrete pillar 
for healthy society. Children between age 1 to 3 are easily prone to disease due to dietary 
habit of mother or of the  child , if the baby has started consuming solid foods. 
 These days working women may find difficult to maintain good feeding frequency so 
as to fulfil the child‟s need as they are not available to feed often when the child requires 
,which leads to supplementary foods and increased the chance of  indigestion. Other than this 
the altered food habits of the mothers also causes indigestion.Hence much care is really 
essential to prevent as well as to cure digestion problems in children. 
 Mantham is one of the diseases mentioned in Balavagadam
 
 and it is classified into 21 
types. It illustrate that when mother feeds baby after having foods like mangoes, jack fruit 
and oily foods etc, may affect childs health mentally and physically.  
 As per siddha literature kattu mantham is one among the 21 types of mantham. It is 
common in children between the ages of 1 to 3 years. 
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 According to
 
T.V.Sambasivampillai Tamil-English dictionary
  
, kattumantham is a 
disease in children arising from constipation. It is marked by indigestion, stomach pain, 
cough, fever, yawning, perspiration etc. It may be correlated with dyspepsia in modern 
science.    
Functional dyspepsia is defined as persistant or recurrent pain or discomfort centered 
in the abdomen, without evidence or organic disease. It is a functional disease in which the 
gastrointestinal organ primarily the oesophagus, stomach, small intestine & colon function 
abnormally.The primary symptom of dyspepsia are upper abdominal pain, abdominal 
bloating, early satiety and these symptoms are most often provoked by eating.  
The incidence of dyspepsia in children above one year is 85% in pediatric population. 
In the Out patient department of Ayodhidoss Pandithar hospital, National Institute of Siddha 
around 1500 patients is visiting every day for treatment for various ailments. Among them,         
3 - 5% of patients is in pediatric group and is mostly affected by common digestive problem. 
As no objective structural or pathophysiological measure exist to assess outcome one has to 
rely on the subjective reporting of symptoms by the patients and their impact on normal daily 
activities to decide whether a treatment intervention is of benefit or not. 
               In Balavagadam, there is a Sastric Siddha formulation seenthil kudineer for 
KattuMantham(dyspepsia) which is also mentioned in Gunapadam mooligai vaguppu. The 
main ingredients of the seenthil kudineer are seenthil, sukku ,sivathai which are known for 
their stomachic, carminative, laxative action. It is said to be cost effective also but efficacy of 
this medicine is not yet scientifically validated Hence, I have selected Seenthilkudineer for 
my clinical trial. 
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2. AIMS AND OBJECTIVES: 
Primary Aim and Objectives: 
To evaluate the efficacy of seenthil kudineer for the management kattu mantham in Children 
under the following preclinical and clinical parameters 
 Physico – chemical Analysis,  , Carminative studies, Chemical analysis of trial 
drug 
 Clinical studies 
Secondary objectives: 
 To collect and review the ideas mentioned in the ancient Siddha literature 
about the disease kattu mantham. 
 To explore Definition, Etiology, Clinical features, Diagnosis, Investigations 
and treatment of kattu mantham as laid down from various siddha literature. 
 To make the correlative study of the siddha and modern aspect of this 
diseases. 
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SIDDHA ASPECT 
khe;jk; 
NtWngah;fs; 
    ke;jk;> myrk;> myrfk; vd gps;isg; gpzp kUj;Jt Ehypy; Fwpg;gplg;gl;Ls;sJ.  
,ay; 
 ke;j ,ay;GilaJ khe;jk; vdg;gL;k;. ke;jk; vd;gJ cUt epiyap;y; 
cly;epiyapy; ke;jk;. mUtepiyapy; mff;fUtpfshfpa kdk;> Gj;jp> rpj;jk;> 
mfq;fhuk; Mfpa midj;J me;j; fuzq;fspYk;  ke;jk; vd FOe;ij  
kUj;Jtj;jpy; nfhLf;fg;gl;Ls;sJ.   
 cz;l czT nrhpahky; tapw;wpy; Gspj;J tapW cg;gp ,iue;J  ke;jj;ij 
cz;lhf;fp the;jpiaAk; fopr;riyAk; cz;lhf;fp Jd;gj;ij  Vw;gLj;Jk; Neha; vd 
gps;isg; gpzpkUj;Jtj;jpy; Fwpg;gplg;gl;Ls;sJ. 
Neha; tUk; gUtk;: 
 jhyg;gUtk;> rg;ghzpg; gUtk;> Kj;jg; gUtk;> tUifg; gUtq;fspy; 
cz;lhf;f$ba NehahFk;. 
Foe;ijapd; Kjy; Mz;by; ,Ue;J %d;W Mz;Lfs; tiu njhlUk; vd 
Foe;ij kUj;Jtk; kw;Wk; jd;te;jphp Foe;ij thflj;jpy; Fwpg;gplg;gl;Ls;ssJ. 
,e;Neha; 3 khjk; Kjy; 12 taJ tiu tuf;$baJ. ghy; kl;LNk Fbf;Fk; 
gUtk>; ghYk;> NrhWk; cz;Zk; gUtk;> NrhW kl;;LNk cz;Zk; gUtk; Mfpa 
Kd;W gUtq;fspYk; khe;jk; Vw;gLk; vd gps;isg;gpzp kUj;Jtj;jpy; 
Fwpg;gplg;gl;Ls;sJ. 
Neha; tUk; top 
  ePh; epiyfspy; gOj;J> cjph;e;j rUFfs; tpOe;J mOfpapUf;Fk; ePiuf; 
Fbj;jy;. 
 vUikg;ghy;> Gspj;j vUikNkhh;> vUik nea;. thiog;gok;> khk;gok;> 
Njq;fha;> ,sePh;> fliy> nty;yk;> fhl;;Lj; Jtiu> nkhr;irf;nfhl;il> 
Gspaq;nfhl;il> gUg;G cUz;il> khtpdhy; nra;ag;gl;l nghUl;fs;> mjpurk;> 
thAg;nghUl;fs;> NrhW ,itfis mjpfkhf cz;zy; Kjypa fhuzq;fshy; 
khe;j Neha; cz;lhFk; vd Foe;ij kUj;Jtk; Fwpg;gpLfpwJ. 
 ke;jg; nghUshfpa vUikg;ghy;> nea;> thiog;gok;> khk;gok;> fliy> nty;yk;> 
khkprk;> gUg;G cSit kPd;> tuhy; kPd;> nfz;il Mfpatw;iw Foe;ijfs  
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cz;Zk;NghJ khe;jNeha; cz;lhFk; vd jd;te;jphp Foe;ij thflk; 
$WfpwJ. 
 ghfw;fha;> Riu> cSe;J> Cd;> nghpa cSit kPd;> thiskPd;> gd;wp 
,iwr;rp> tpuhy;kPd;> nfz;il kPd; Mfpa Mfhj nghUl;fs; cz;gjhYk;> 
khe;jNeha; cz;lhFk; vd gps;isg;gpzp  kUj;Jtk; Fwpg;gpLfpwJ. 
 NkYk; NrhW kl;LNk cz;Zk; Foe;ijapd; czT Fw;wj;jpdhYk; cztpd; 
NtWghl;lhYk; khe;jk; Vw;gLk;. 
 Foe;ijapd;  Ja;ikaw;w  jd;ik> rhpahd Neuj;jpy; rhg;gplhJ Neue;jtwp 
rhg;gply;> Rj;jkw;w czTg; nghUl;fisr;rhg;gply;> clk;gpy; Nghjpa 
Cl;lr;rj;J ,y;yhj epiy Mfpa fhuzq;fspdhYk; ,g;gUtj;jpy; ,;e;Neha; 
tUk;. 
 cztpdhy; kl;Lkpd;wp nraypd; NtWghl;lhYk; khe;j Neha; Foe;ijiaj; 
jhf;Fk;. tWik> grp> Jauk;> kdf;ftiy> gak;> Nfhgk;> ,r;ir Nghd;w 
czh;Tfshy; Foe;ijahdJ jhf;FWk; NghJ czTr;nrhpf;Fk; jd;ikapy; 
khWghL epfo;e;J khe;jk; cz;lhfpwJ vd gps;isg;gpzp kUj;Jtk; $WfpwJ. 
 Nkjpg;ghy;> nea;> fjypg;gok;> Njq;fha;> ,sePh;> nty;yk;> Gspj;j Nkhu;> khkprk;> 
fdpfs;> cSe;J> nkhr;ir> Gspaq;nfhl;il> cSit> nfz;ilkPd;> ghfy;> 
Riu Kjyhd thAg; gz;lq;fis ghy; nfhLf;Fk;  khju;fs; kpFjpahf 
cz;lhy; my;yJ Foe;ijfs; mjpfkhf cz;lhy; khe;j Neha; cz;lhFk;  
vd Mtp mspf;Fk; mKj Kiw RUf;fj;jpy; Fwpg;gplg;gl;Ls;sJ 
Neha; tiffs; 
Foe;ij kUj;Jtj;jpy; khe;j Neha; 21 tiffshfg; gpupf;fg;gl;Ls;sJ  
1. tsp khe;jk;                            
2. moy; khe;jk; 
3. Iak; khe;jk;  
4. tply; khe;jk; 
5. Nghh; khe;jk; 
6. thiy khe;jk; 
7. Ruk; khe;jk; 
8. ePh; khe;jk; 
9. nrhpah khe;jk; 
10. fl;L khe;jk; 
11. ghy; khe;jk; 
12. vhp khe;jk; 
13. Jis khe;jk; 
14. Jiy khe;jk; 
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15. fzk; khe;jk; 
16. typg;G(,Og;G) khe;jk; 
17. Rop khe;jk; 
18. Kf;F khe;jk; 
19. re;ep khe;jk; 
20. Cjy; khe;jk; 
21. tPf;fk; khe;jk;  
,J jtpu NkYk; 10 tif Fwpg;gplg;gl;Ls;sd. 
1. cg;gy; khe;jk; 
2. the;jp khe;jk; 
3. twl;rp khe;jk; 
4. jpl;L khe;jk; 
5. cis khe;jk; 
6. mf;fuk; khe;jk; 
7. Nga; khe;jk; 
8. ePh;fzk; khe;jk; 
9. Njhlk; khe;jk; 
10. fUg;gk; khe;jk;  
 vdTk; kw;nwhU tifg;ghl;bd; gb> vz;tif khe;jk; fPo;f;fz;l tiffs; 
nfhLf;fg;gl;Ls;sJ. 
 
1. nghJ khe;jk; 
2. nrhpah khe;jk; 
3. jiy khe;jk; 
4. Nghh; khe;jk; 
5. fl;L khe;jk; 
6. tpl khe;jk; 
7. ePu; khe;jk; 
8. Rop khe;jk; 
jd;te;jphp ghythflj;jpy; khe;jNeha; 21 tiffshf tifg;gLj;jg;gl;Ls;sJ 
1. moy; khe;jk; 
2. Cjy; khe;jk; 
3. vhp khe;jk; 
4. Iak; khe;jk; 
5. fzk; khe;jk; 
6. re;ep khe;jk; 
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7. Ruk; khe;jk; 
8. Rhp khe;jk; 
9. nrhpahik khe;jk; 
10. jiy khe;jk; 
11. Jiy khe;jk; 
12. ePu; khe;jk; 
13. ghy; khe;jk; 
14. Nghu; khe;jk; 
15. Kf;F khe;jk; 
16. typg;G khe;jk; 
17. tsp khe;jk; 
18. thiy khe;jk; 
19. tplk; khe;jk; 
20. tPf;fk; khe;jk; 
mDgt itj;jpa Njtufrpaj;jpy; 8 tiffs;;;: 
1. nrhpah khe;jk; 
2. gPh; khe;jk 
3. Ru khe;jk; 
4. tp~ khe;jk; 
5. Rop khe;jk; 
6. CJ khe;jk; 
7. ePh; khe;jk; 
8. jiy khe;jk; 
kjiy Neha; Ehypy; khe;jk 13 tiffshfg; gphpf;fg;gl;Ls;sJ. 
(Fk;g Kdp ghythflk;) 
   “Njhd;wpa thj gpj;jk; nrhy;ypa rpnyw;g khe;jk; 
 Cd;wpaajLf;F khe;jk; tpr khe;jk; Nghh; khe;jk jhd; 
 fd;wpaghy; khe;jk; td;fg khe;jk nghJ khe;jk; gpd; 
 te;jpLk; tpidahk; rd;dp typ rh;j;jp gjp%d;whjhNk” 
mitahtd: 
1. thj khe;jk; 
2. gpj;j khe;jk; 
3. rpNyw;gd khe;jk; 
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4. eLf;F khe;jk; 
5. tp~ khe;jk; 
6. Nghh; khe;jk; 
7. ghy; khe;jk; 
8. td;fg khe;jk; 
9. nghJ khe;jk; 
10. tpid khe;jk; 
11. rd;dp khe;jk; 
12. typ khe;jk; 
13. rhj;jp khe;jk; 
 
gps;isg;gpzp kUj;Jtk; :  
Definition:   
Indigested food in the stomach causes abdominal distension and manifests as Mantha 
Noi with vomiting and diarrhoea. 
“ke;jkJ tuyhW nrhy;yf; NfsPu; 
khjNuhL ghyfU kUe;Je; jPdp 
Nru;e;jnjhU ghy;jdpNy tpre;jhd; nfhz;L 
rpWtUf;F cjuj;jpy; ke;jk; gw;wp 
Cu;j;nj*e;j jpiuapdhy; tpuzq;nfhz;L 
cs; tpuzk; gy NehT cwt jhfp 
rhu;e;j kyk; rpf;fpajpy; Njhr Kz;lha; 
jhnd*k;Gk; khe;jtif rhw;W NtNd” 
     --gps;is gpzp kUj;Jtk; 
The above verse states that Mantham occurs in children due the diet taken by the 
mother and the child, which causes indigestion and other related diseases.  According to the 
Pillai Pini Maruthuvan text, Mantham occurs from the age of 3 months to 12 years in 
children. particularly   while child having breast milk(Exclusive  Breast Feeding), then   
weaning  period during  which   both milk and solid foods  were given and later  stage  where 
the child given solid feeds (late weaning period). 
During the period of exclusive breast feeding if the mother  takes food  which is not  
digestable  in large amounts.  The child becomes affected by Mantha Noi due the intakeof 
mother‟s devitalized milk.  The psychological feelings of the mother also affects the quality 
of milk given to the child. 
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During the weaning period, due to the diet taken by both the mother and the 
childcauses Mantha Noi.  The psychosomatic feelings of mother like hunger, poverty, anger, 
fear, desire affects the efficacy of the milk fed to the child in this period. 
                 During the late weaning period, the disease occurs mainly due to the improper 
food habits of children like taking not easily digestable foods, taking cleanless foods, taking 
irregular meal and taking imbalanced diet.  Malnourished children are also affected by 
Mantham.  
gps;isg;gpzp kUj;Jtk; ghfk; 2y; khe;jj;jpd; tiffs;- 53 
In Pillai Pini Maruthuvam part 2 (Types 43) 
1. Adai Mantham 
2. Atcha  Akkara Mantham 
3. Azhal Mantham 
4. Allu Mantham 
5. Eluppu Mantham 
6. Uppal Mantham 
7. Uppu Mantham 
8. Ulai Mnatham 
9. Oothu Mantham 
10. Eri Mantham 
11. Iya Mantham 
12. Kattu Mantham 
13. Kana Mantham 
14. Karppa Mantham 
15. Kanai Mantham 
16. Kal Mantham 
17. Kazhi Mantham 
18. Sakthi Mantham 
19. Sanni Mantham 
20. Sanni Bhatha Mantham 
21. Sura Mantham 
22. Suzhi Mantham 
23. Seriya Mantham 
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24. Thalai Mantham 
25. Thittu Mantham 
26. Neer kana Mantham 
27. Thulai Mantham  
28. Neer Mantham 
29. Pal Mantham 
30. Pul Mantham 
31. Bethi Mantham 
32. Pei Mantham 
33. Por Mantham 
34. Maladi Mantham 
35. Mukku Mantham 
36. Valippu Mantham 
37. Vali Mantham 
38. Varatchi Mantham 
39. Vanthi Mantham 
40. Val Mantham 
41. Vida Mantham 
42. Thoda Mantham  
43. Veekka Manthamare described. 
         43 tif khe;jq;fs; FwpFzq;fSld; fhzg;gLfpd;wd. 
kPjKs;s10 khe;jq;fs; ngaustpy; kl;Lk; tifg;gLj;jg;gl;Ls;sJ. 
Foe;ij kUj;Jtj;jpy; khe;jj;jpd; nghJ FwpFzq;fs;: 
 Foe;ijapd; clk;G Nrhu;e;J ,Uj;jy; 
 clk;G Nehjy; 
 kpFjpahd tpau;it cz;lhjy; 
 RWRWg;ghf ,y;yhky; fz;tpop rpte;jpUj;jy; 
 fz;fs; Fop tpOe;J fhzy; 
 Kfk; ntSj;J xU tif kq;fpa xsp fhzy; 
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 Fuy;jsu;e;J tha;cyu;e;Jfhzy; 
 Mbf;fb the;jp Vw;gly; 
 Grp ,d;ik fhzy; 
 rPjKk; kyKkhfTk;> nfl;LNghd ghy; NghTyk;> jz;zPu; NghyTk; gy 
epwkhf Ngjpahjy; 
 if fhy;fs; #L ,y;yhky; Fspu;e;J fhzy;  
fl;L khe;jf; FwpFzk; 
“jhahh; Kiyapy; tha;itj;Jr; 
rw;Nw Az;Zk; jpifj;jpUf;Fk; 
                      Xah jOif rpw;wpUky; 
                      cs;Ns RuK kpfTz;lhk; 
                      Nrah kyKQ; ryq;fl;br; 
                      rpf;fg; gz;Zk; grpapy;iy 
                      khah krf;F kpJfl;L 
                      khe;j nkd;W tFj;jdNu” 
                    -ghythflk; 
FwpFzk; 
1. kyk; ryk; fl;LgLk; 
2. rw;Nw ghYz;Zk; 
3. grpapd;ik  
4. Ruk; 
5. nfhl;lhtp 
6. rpw;wpUky; 
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Kf;Fw;w NtWghL 
 
czT Ntw;Wik 
 
Kf;Fw;w khWghL 
 
 
thA NfL miljy;(cjhdd; ghjpg;G) 
 
 
mghdd; ghjpg;G 
 
rkhdd; ghjpg;G 
 
jPf;Fw;w ghjpg;G 
(mdw;gpj;jk; ghjpg;G) 
 
czT nrhpahik 
 
khe;jk; 
 
Kf;Fw;w epiyfs;: 
A. Vali:  
Site of vadham in body: thjk; thOkplk ; 
              Abaanan, faces   idakalai, below the umblical region, spermatic cord, pelvic bones, 
skin, nerve plexus, joints, hair follicle, muscle, alimentary tract, bones, ear and thighs. 
NkYk;: 
  “mwpe;jpLk; thj klq;F kyj;jpdpy;”- jpU%yh; 
  “ehnkd;w thjj;Jf; fpUg;gplnk Nfsha; 
  ehgpf;Ff; fPnod;W etpy yhFk;" - A+fp Kdptu;. 
vd;gjhy; kyKk;> ehgpf;F fPoplKk ;thjkpUf;Fkplq;fs;vd nfhs;syhk;   
                                  rpj;jkUj;Jthq;fRUf;fk;(g.vz;.139) 
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Vadham consists of 10 types  
1. Praanan: (Uyirkaal)  
This controls knowledge, mind and five sense organs, which are useful for breathing 
and digestion.   
2. Abaaban: (Keezh nokkung kaal)  
This is responsible for all down ward movement such as passing urine, stools, semen, 
and menstrual flow. Abaanan vayu is affected in Kattu mantham due to constipation 
3. Samaanan: (Nadukkaal)    
This aids in proper digestion and controls other vayus. In Kattu mantham, this vayu is 
altered leading to poor appetite and cannot control the other vayus. 
4. Viyaanan: (Paravukaal)  
This is responsible for all movements of all parts of the body and distribution of 
saaram. This vayu is affected in Kattu mantham because of decreased activity due to 
symptoms like constipation. 
5. Uthaanan: (Mel Nokkung kaal)  
Responsible for all upward movements such as vomiting and nausea.It distributes the 
saaram equally to all tissues.It is affected in Kattu mantham because unequal distribution of 
saaram and presence of cough 
6. Naagan:  
Responsible for opening and closure of eye lids  
7. Koorman:  
Responsible for vision and yawning. .  
8. Kirukaran:  
This is  responsible for salivation, nasal secretion, sneeze, cough and maintains the 
appetite. In Kattu mantham, this vayu is affected due to presence of cough and poor appetite. 
9. Devathatthan:  
This is responsible for tiredness (Lazziness), anger and emotional expression.  This 
vayu is deranged in Kattu mantham because some patient had tiredness.  
10. Dhananjeyan:  
It produces swelling of the body after death. It escapes on the third day after death 
bursting out of the cranium.  
rpj;j kUj;Jthq;f RUf;fk;(g.vz;.142 - 149) 
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ii. Azhal:  
Sites of pitham in body:  
Pinkalai, praanavayu, urinary bladder, moolakkini, heart, head, umblical region, stomach, 
sweat, saliva, blood, saaram, eyes and skin. 
“gpupe;jpLk;  gpj;jk; Nguhk; ryj;jpdpy;” -  jpU%yh; 
“Nghnkd;w gpj;jj;Jf; fpUg;gplNk Nfsha; 
Nguhd fz;lj;jpd; fPNo jhFk;” - A+fpKdptu; 
$wpapUg;gjdhy; rpWePUk;> fz;lj;jpd; fPoplKk; gpj;jk; ,Ug;gplkhFk;. 
                           rpj;j kUj;Jthq;f RUf;fk;(g.vz;.153) 
 
Pitham consists of 5 types  
1. Anal pitham:  
It promotes appetite and helps in digestion. In Kattu mantham, it as affected due to 
presence of poor appetite.  
2. Ranjagam:  
It gives colour to the blood. In Kattu mantham, some children are anaemic.  
3. Saadhagam:  
It is important for day today activities with the help of mind and brain.  
4. Praasagam:  
It gives complexion to skin.   
5. Aalosagam: 
It brightens eyes and responsible for clear vision.  
- rpj;j kUj;Jthq;f RUf;fk; (g.vz;.155-157) 
iii. Iyam:  
Sites of Kabam in body:  
Kabam (or) kapham is located in sammana vayu suzhumunai, sperm, head, tongue, 
uvula, fat, bone marrow, blood, nose, chest, nerve, bone, brain, large intestine, eyes, and 
joints and also present in throat, stomach and pancreas.  
-   -rpj;j kUj;Jthq;f RUf;fk; (g.vz;.158) 
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Kabam consists of five types  
 
1. Avalambagam:  
It lies in the lungs. It controls the heart and other four kabams.  
In Kattu mantham, it is deranged due to presence of cough. 
2. Kilethagam:  
It lies in the stomach and gives moisture to food material and also helps for digestion. 
In this disease, it is affected because of  the poor appetite present in children.  
3. Pothagam:  
It lies in tongue and responsible for taste sensation.  
4. Tharpagam:  
It is present in the head and responsible for coolness of both eyes.  
5. Santheegam:  
It is present in joints. Responsible for lubrication and free movements of joints.  
 
- rpj;j kUj;Jthq;f RUf;fk;(g.vz;.161 - 163) 
 
PINIYARI MURAIMAI: (DIAGNOSIS) 
 Piniyari muraimai is a method of diagnosing a disease. The way of diagnosis is very 
important to the physician who deal the disease, because of that only he or she can pont out 
the cause of disease. 
 ,jidNa jpUts;Stu; jpUf;Fwspy; gpd;tUkhW $Wfpwhu; 
“Neha;ehb Neha;Kj dhbaJ jzpf;Fk; 
tha;ehb tha;g;gr;nray;”– jpUf;Fws;  
 
Siddha system has a very unique method for diagnosis. This is based upon three 
principles.  
1. Poriyaal arithal (Inspection)  
2. Pulanaal arithal (Palpation)  
3. Vinaathal (Interrogation)  
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I. Poriyaal arithal:  
Porigal means the five sense organs. These are eyes, ears, nose, tongue and skin. 
Poriyaal arithal is examining the five sense orgn of the patient by the five sense organ of the 
physician.  
In kattu mantham, 
Mei (skin)   -  Normal  
Vaai (Tongue)  - Normal 
Kann (Eye)    -  Normal 
Mookku (Nose)  -  Normal 
Sevi (Ear)   -  Normal  
 
II. Pulanaal arithal:  
Pulan means sense of perception from the five sense ongans.That means 
understanding by the sense objects.  
 
In Kattumantham,  
Ooru (sensation) -  Normal 
Oosai (sound)   -  Normal 
Oli (vision)   -  Normal  
Suvai (Taste)  -  Normal 
Naatram (smell)  -  Normal 
 
III. Vinaathal:  
Vinaathal means the physician should know about the patients name, age, occupation, 
family history, socio-economic status, diet and habits, complaints, relevant to disease in his 
family by asking questions. 
 
Ezhu udar kattugal and Ennvagai thervugal also used for diagnosing a disease in 
Siddha system 
Ezhu udar kattugal:  
1. Saaram  
2. Senneer  
3. Oonn  
4. Kozhuppu  
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5. Enbu  
 
6. Moolai  
7. Sukkilam/suronitham  
 
When the seven udar kattugal increase or decrease from the normal level, the normal 
functions of the body will be affected. 
 
In  kattu mantham. 
 
a. Saaram   :  Deranged due to poor appetite causing tiredness. 
 
b. Senneer   :  Deranged in some patient with nutritional anaemia. 
 
c. Oonn   :  Normal 
 
d. Kozhuppu  : Normal 
 
e. Enbu   : Normal 
 
f. Moolai   :  Normal.  
 
g. Sukkilam/  
Suronitham  :  Normal  
 
 
The diagnostic value of Enn vagai thervugal is specific to siddha system of medicine.  
 
Enn vagai thervugal are:  
1. Naadi (Uyir thathu)  
2. Sparisam (Touch feel sensation)  
3. Naa (Tongue)  
4. Niram (Colour of the skin)  
5. Mozhi (Quality and character of speech)  
6. Vizhi (Eye)  
7. Malam (Stools)  
8. Moothiram (Urine)  
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Naadi (Uyir thathu) : 
 Envagai thervugal is the basic diagnostic principles and the uniqueness of the siddha 
system of medicine. The following lines are said about this. 
“nka;f;Fwp epwe;njhdp tpop 
ehtpUkyk; iff;Fwp” 
             -rpj;j kUj;Jthq;f RUf;fk5;(g.vz;.483) 
 Otherwise known as uyir thathu, is the principle method for diagnosis in siddha 
system. The naadi indicates the status of the body thathus and whether the body is normal or 
abnormal. It is responsible for existence of life in the physical body. It is said in literatures as 
clypy; capu;jhpj;jpUg;gjw;F fhuzkhd rf;jp vJNth mJNt “jhJ my;yJ ehb” 
vdg;gLk;. 
  “ehbg;guprk; ehepwk; nkhoptpop 
  kyk; %j;jpukpit kUj;Jt uhAjk;” 
- Neha; ehly; Neha; Kjdhly ; g.vz;. 270) 
In childrens the naadi nadai is not clearly seen. This is indicated by following lines,  
 
“nfhz;blNt faNuhfp fhrNuhfp  
Fwpg;ghfr; rpw;wpd;gk; nra;j Ngh;fs;  
mz;blNt jhpj;jpuHfs; tpUj;jH ghyh; 
md;ghfj; jz;zPhpy; %o;fpNdhHfs;  
nfhz;blNt ,th;fsJ cWg;gpd; jhJ  
$wNt KbahJ vth;f;Ff; fpl;Lk;” 
- Neha;ehly; Neha; Kjdhly; (g.vz;:171). 
-  
b) Sparisam: (Touch feel sensation)  
 Identify the heat or coldness of the body, pain and skin nature (soft or hard)  
In kattu mantham,  
 It may be hot due to fever.  
 It may be cold due to sweating.  
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c) Naa: (Tongue)  
 It is noted for colour of the tongue local lesion (ulceration, redness), coating 
deposition of tongue and dryness of the tongue.  
d)  Niram: (Colour of skin)  
Colour of skin, conjunctiva, teeth, tongue, nail bud and hair are note In Kattu 
mantham, Conjunctiva, nail bud may be pale due to nutritional anaemia. 
e) Mozhi : (Quality and character of speech)  
 
  Observation of speech and voice. This is said in Agasthiar vallathi as  
                         “thu;j;ijiag; ghu;” 
In Kattu mantham normal voice is present. 
f)  Vizhi  : (Eye)  
By this examination, colour of eye (redness, pallor) protrusion, tears, excreta of eye, disease 
of eyes are noted.  
In Kattu mantham, the eyes of Some patients have pallor of lower eyelid due to nutritional 
anaemia.  
g) Malam  : (stools)  
Consistency of stool will be like hard pellets like, foul smell, decreased frequency of 
defeacation, constipation,lesser  quantity of stool are noted.  
 In Kattu mantham, patient have hard pellets like  stools and decreased frequency of 
passing stools. 
 
h) Moothiram : (Urine)  
 
Colour of urine (yellow, black, white copper colour, mixed colour. Then smell of 
urine (smell of fire, honey, sweet odours, fruity odour) frothy or not, decreasesd frequency of 
urination and quantity of urine are noted.  
 In Kattu mantham, there will be normal straw yellow  colour of urine with decreased 
frequency of urine. 
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Neer nira kuri and Nei kuri: 
This urine examination is unique in Siddha system of Medicine 
ePu;epwf;Fwp:- 
                “mUe;J khwpujKk; mtpNuhjkjha; 
                mfy; myu;jy; mfhyT+d; jtpu;e;jow; 
                Fw;wstUe;jp cwq;fp itfiw 
                Mbf;fyrj; jhtpNa fhJ nga; 
                njhUK$u;j;jf; fiyf;Fl;gL ePupd; 
                epwf;Fwp nea;f;Fwp epwkpj;jy; flNd” 
 
- Neha; ehly;Neha; Kjdhly; (g.vz;. 282) 
Collection of sample urine:- 
 
The patient must take well cooked food in the previous day. Food intake should be 
taken at correct time and avoid excessive intake. The urine is collected on the dawn of the 
next day in a pure glass container and closed immediately to prevent contamination. This 
specimen must be examined with in one and half hours from the collection.  
 
nea;f;Fwp:- 
 
             “epwf;Fwpf; Fiuj;j epUkhz ePupw; 
             rpwf;f ntz;nza;Nahu; rpWJsp eL tpLj; 
             njd;Wwj; jpwe;njhyp Vfhjikj;jjp 
             dpd;wjptiy Nghk; newp tpopawpTk;  
             nrd;wJ GfYk; nra;jpia AzNu” 
- Neha; ehly; Neha; Kjdhly; (g.vz;. 298) 
A drop of gingelly oil is dropped on a wide glass vessel containing the urine to be 
tested which is kept under sunlight in a calm place. The derangement of three dhoshas can be 
diagnosed by the mode of spread of gingelly oil on the surface of urine.  
In Kattumantham the results of nei kuri is snake  like oil floating on urine in some 
patients and ring like structure on urine in some patients.  
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MARUTHUVAM:  
          The treatment in siddha medicine is aimed at keeping the Mukkutram in the state of 
equilibrium.  
i.e,  
 Highly vitiated vatham to normal level  
 Vitiated pitham to normal level  
 Vitiated kabam due to vitiated vatham to normal level.  
 To strengthen the seven udar kattugal and maintains the normal level.  
          Keeping in mind the need for bringing out an effective therapy for Kattu mantham with 
the  Seenthil kudineer. 
Line of treatment:  
           Siddha treatment is not only for to cure the disease but also teaches prevention and 
rejuvenation concepts.  
Saint Thiruvalluvar says about the duty of a physician as follows 
 
           “Neha;ehb Neha;Kj dhbaJ jzpf;Fk; 
          tha;ehb tha;g;gr;nray;”– jpUf;Fws; 
          “cw;whd sTk; gpzpasTq; fhyKq; 
          fw;whd; fUjpr; nray;”– jpUf;Fws;. 
 
From the above verse, it is essential to know the etiology, the nature of patients, 
severity of the illness, the seasons and the time of occurrence the disease must be observed 
clearly.  
Line of treatment is as follows:  
1. Kaappu (prevention)  
2. Neekkam (Treatment)  
3. Niraivu (Restoration)  
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1. Kaappu: (prevention)  
Prevention is the main aim of siddha system. Siddhars have described general 
preventive measures and special measures.  
Especially in Balavagadam, special preventive measures said for prevention of 
disease of the child. It starts from the conception and goes on the child grows up in intra 
uterine life and after delivery. ie diet of pregnant women, her habits, medicine to take in 
every month of pregnancy, her psychological conditions and surroundings. 
 
2. Neekkam: (Treatment)  
The aim of treatment is based on  
 To bring the three thodams into normal equilibrium state.  
 To treat the patients according to the symptoms by internal medicine Seenthil 
 kudineer 
i. Anupanam in Siddha system : 
       “mDghdj;jhNy ato;jk; gypf;Fk;;> 
      ,dpjhd Rf;F fd;dy; ,;Q;rp – gpDKjfhy; 
                NfhNkak; ghy; Kiyg;ghy; Nfhnea; Njd; ntw;wpiy ePu;;;:> 
                   Mkpij ahuha;e;J nra;ayhk;” 
                                                                                                      
- Njiuau; ntz;gh 
 
 Siddha system considers anupanam as an important. It is otherwise known as “Thunai 
marunthu”, it can be translated as vehicle, adjuvant and supporting to drug therapy. Without 
anupanam, success in the treatment is mostly not possible.           
                                                  
  ii. Pathiyam:  
During the course of treatment, the patients were advised to follow certain restrictions 
regarding diet and physical activities.  
This type of medical advice termed as pathiyam. Importance of pathiyam is said by 
Siddhars Theraiyar as follows,  
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   “gj;jpaj;jpdhNy gyDz;lhFk; kUe;J 
   gj;jpaq;fs; Nghdhy; gyd; NghFk; - gj;jpaj;jpy; 
   gj;jpaNk ntw;wpjUk; gz;bju;f;F Mjypdhy; 
   gj;jpaNk cj;jpnad;W ghu;” 
- Njiuau; ntz;gh. 
The patient with Kattu mantham is advised to avoid spicy and hot food , contaminated 
water , junk foods . 
 
3. Niraivu: (Restoration)  
 Reassurance of disease recovery was given to all patients.  
 All the patients are advised to prepare for lifestyle changes  that provides a disease 
free life.  
 
Diet: 
 
Siddhars advise the diet regimens for Kattu mantham patients. They are explained 
below:  
 
“fj;jphp Nga;Gly tiu apUghfy; gUq;fhsh fz;lfhhp  
mj;jpf; fha;fSk; tUf;ifkhgaw;iw fiuahy; gPHf;fUk; gpQ;RNth;  
nkha;j;j #uzq; fjypj; jz;Lfisg; G+Ksq;fp KUf;fUk;Gk;  
mj;jp G+rzpf; fhaUs;sp ts;spAq; fgj;NjhHf; fhzkhNk” 
 
                                     - gjhHj;j Fz rpe;jhkzp.  
 
“Ntis kzj;jf;fhsp nkd;rPij rf;futh;j;jp  
gPis triy Rf;F ngz;fzq;fs; - Ntisapy;  
nre;jspH fisf;fPiu nra;th; fgNjfH epjk;  
te;jspAzj;jhd; kfpo;e;J” 
                                    - gjhHj;j Fz rpe;jhkzp.  
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fha;fwpfs;:- 
 fj;jhp  
 Nga;Gly;  
 mtiu  
 fz;lq;fj;jphp  
 mj;jpf;fha;  
 gPHf;F  
 thioj;jz;L  
 KUq;if  
 ghfy;  
 G+rzp  
 
NtHf;fpoq;Ffs;:- 
 
 Ks;sq;fp  
 <Us;sp  
 
fPiufs;:- 
 
 kzj;jf;fhsp  
 rpWfz;gPis  
 triy  
 rpWfPiu  
 nghd;dhq;fd;dp  
 rf;futh;j;jp fPiu  
 Rf;F fPiu  Mfpaitfis cztpy; Nru;j;Jf; nfhs;sNtz;Lk;. 
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MODERN ASPECTS 
GASTROINTESTINAL  TRACT: 
The GI tract is the pathway were food passes from the mouth, through the esophagus, 
stomach, small and large intestine within where the nutrients are extracted for the needs of 
the body. The residue then passes to the rectum where it is evacuated. 
 
 
 
 
ANATOMY OF THE GASTROINTESTINAL TRACT: 
1. The Esophagus:  
The first part of the pathway of GIT is the esophagus, which  guides food from the 
mouth, where it is prepared by chewing, down to the stomach where it is stored. 
2. The Stomach: 
The stomach is both a storage space, holding as much as a quart and a half of ingested 
food, and a secretory organ that produces the gastric acid necessary for digestion However, 
the stomach does not absorb food. When food enters the stomach from the esophagus it 
remains for a short period while it is mixed with gastric acid. The stomach then by 
involuntary muscle contractions (peristalsis) empties the food gradually into the duodenum, 
the first part of the small intestine. 
3. The small Intestine: 
The small intestine consists of three parts: the duodenum, the jejunum and the ileum. 
In these three parts, certain digestive secretions are mixed with food, and the nutrients are 
absorbed into the blood stream 
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The Duodenum: 
The duodenum treats the food it receives with bile from the liver and enzymes from 
the pancreas. It also adds liquid duodenal fluid that comes from the wall of the duodenum 
itself.The food, bile, enzymes and liquids brought together in the duodenum are then passed 
into the jejunum 
II. The Jejunum : 
The jejunum or second portion of the small intestine is approximately 10 feet long. It 
lies immediately behind the duodenum and continues the process of digestion, breaking down 
food into essential elements 
 III.The Ileum: 
The ileum or third portion of the small intestine, like the jejunum, is about 10 feet 
long. It is here that a major part of the absorption of food products and liquids occurs. Waste 
products of the digestive process are passed from the small intestine or terminal ileum, into 
the large intestine, also known as the colon. 
4. Large Intestine (colon): 
 The colon moves waste products through about four feet by the continuing process of 
undulating motions or peristalsis, which is common to all parts of the gastrointestinal tract. 
The primary function of the colon is to store waste products of digestion prior to evacuation. 
The colon absorbs small amounts of water and electrolytes. 
 
COMMON GASTROINTESTINAL TRACT DISORDER: 
Functional gastrointestinal disorders are common in children. Our brain and our GI 
tracts are closely connected (the “mind-body connection”). Functional GI conditions are due 
to a combination of extra sensitivity of the GI tract, with changes in the motility or movement 
of the digestive system. 
 
Functional gastrointestinal disorders is specifically manifested as abdomen pain 
,vomiting, early satity,abdomeninal distention,constipation. 
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FUNCTIONAL DYSPEPSIA 
Definition 
Functional dyspepsia is defined as persistant or recurrent pain or discomfort centered 
in the abdomen , without evidence of organic disease. It is a functional disease in which the 
gastrointestinal organ primarily the oesophagus ,stomach, small intestine & colon function 
abnormally. The primary symptom of dyspepsia are upper abdominal pain ,abdominal 
bloating ,early satiety and these symptoms are most often provoked by eating 
Description 
A functional GI disorder refers to a condition where the primary abnormality is an 
alteration in the way the body works (altered function), rather than an identifiable structural 
or biochemical cause. Gastrointestinal motility is defined by the movements of the digestive 
system, and the transit of the contents within it. When nerves or muscles in any portion of the 
digestive tract do not function normally, symptoms only persist. The disturbed motility 
present in functional dyspepsia leads to amplified sensation in the upper gut (visceral 
hyperalgesia).  
Causes ; 
 Some foods  like potatoes chickpeas and other legumes,lentils,foods with lots of 
spices and oils donot get properly digested within body ,they can cause dyspepsia 
 Some psychological causes like child with temper trandum who donot take food 
wholeheartedly. 
 Microorganisms that live within the  lining  of  stomachcan cause irritation which can 
interfere with the digestion process 
 
 Symptoms 
Functional Dyspepsia is due to uncoordinated and uneven  emptying of the upper 
digestive tract, The vast majority of patients experience more than one symptom. 
 
  Pain  in belly 
 Fullness and bloating of abdomen 
  An inability to finish meals 
 Heartburn,  
  sour taste in the mouth,  
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 Excessive burping, nausea, 
 Sometimes vomiting.  
 Characteristically, these complaints are sporadic, poorly localized, and without 
consistent aggravating or relieving factors, 
 Constipation and various foods or additives in the diet can worsen functional pain. 
 
PATHOPHYSIOLOGY 
Functional dyspepsia is usually defined as chronic or intermittent upper abdominal 
symptoms for which no organic cause can be found .Division of functional dyspepsia into 
subgroups such as reflux-like, ulcer-like,dysmotility-like and non-specific dyspepsia has been 
proposed,but lack a scientific basis. 
 The major pathophysiological mechanism responsible for functional dyspepsia 
include psychosocial factors and alteration in motility and visceral sensation.Approximately 
50% of  patients with functional dyspepsia have motor disorders,such as impaired fundic 
relaxation ,antral dilation and hypomotility. 
Patients typically present with gastric hypersensitivity resulting from abnormal 
afferent function. The role of helicobacter pylori in functional dyspepsia is difficult to define. 
Impaired gastric and intestinal reflexes have also been observed in functional dyspepsia. In 
recent years other avenues of pathophysiology are also showing some interest in functional 
dyspepsia. Although both evidence are not sufficient to a significant genetic contribution to 
functional dyspepsia. Some evidence suggest an interaction between polymorphisms of genes 
responsible for components of the immune response and Helicobacter pylori infection among 
some patients with functional dyspepsia. 
 
 DIAGNOSTIC TESTS  
There are no specific diagnostic markers for functional dyspepsia. As with many other 
conditions, a thorough and detailed history taken by a physician is the most important 
component of the assessment and often leads to the correct diagnosis. The history needs to 
include dietary, psychological, and social factors. 
A history may disclose a relationship between symptoms and food, activity, or 
stressors. It is often helpful for the child and parents to maintain a symptom diary detailing 
the time, location, intensity and character of the pain or discomfort, time and content of the 
meals, daily activities, and stool pattern. 
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Considerable diversity of opinion remains among physicians regarding the extent of 
diagnostic tests to perform in a child who seems to have a symptom constellation pointing 
towards a functional cause of the dyspepsia. 
 The diagnostic procedure needs to be individualized, according to the information 
obtained during the history taking and the physical examination. An upper 
gastrointestinal endoscopy is not mandatory. 
 Urine evaluation and blood evaluation to screen for other disease are usually 
necessary. 
 Endoscopy allows the discovery of ulcerations or significant inflammation in the 
upper gastrointestinal tract 
 If the endoscopy is normal, then it may be helpful to monitor for acid reflux (back 
flow of stomach contents into the esophagus). 
 Abdominal ultrasonography does not appear to be helpful in children.  
 Upper gastrointestinal x-rays with small bowel follow-through are useful to exclude 
physical causes such as malrotation [incorrect position of the intestine in the abdomen], 
terminal ileitis [Crohn‟s Disease], and other obstructive or inflammatory lesions. 
 Gastro duodenal manometry is a feasible and useful diagnostic tool in the clinical 
investigation of children  
TREATMENT : 
 The management of dyspepsia revolves around a structural or functional cause. If a 
structural cause is found, the treatment can be specific to the underlying cause. For functional 
dyspepsia, the aim is to provide symptomatic relief. 
 Reduction or avoidance of spicy, fatty, or caffeine-containing food or drink may help 
if associated with symptom onset. 
 Medications such as H2-blockers [reduce amount of acid produced in the stomach], 
 proton pump inhibitors [limit amount of acid produced]  
 Prokinetic agents such as metoclopramide, domperidone, cisapride or erythromycin 
[increase gastrointestinal motility], have been used with some success. 
 There remains a proportion of children who may have a behavioral or psychological 
base to their complaint. For them, treatments such as 
 Environmental modification, 
 Relaxation techniques, 
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 Psychotherapy, 
 Stress reduction, 
 Hypnotherapy, or biofeedback  have been used with variable success. 
 
  PROGNOSIS 
 Functional dyspepsia may come and go and symptoms could present with increased 
severity for several weeks or months and then decrease or disappear entirely for some time 
PREVENTION 
 To avoid or reduce heavy foods like cheese, yogurt, ice cream, peanut butter and 
bananas. Heavy foods overload the digestive system and cause  problems like 
digestion, constipation, congestion and allergies 
 As much as possible children should eat real food, not highly-processed food with lots 
of additives.  
 Sodas and high-fructose corn syrup can harm digestion.Many childrens don‟t tolerate 
diary , gluten or food additives. 
 
DIFFERENTIAL DIAGNOSIS 
              Other disorders can have symptoms that may be similar to or overlap with 
gastrointestinal functional or motility disorders in children. Significantly, these disorders 
have features that a doctor can identify, which distinguish them from functional 
gastrointestinal or motility disorders. 
1. Hirschsprung's Disease 
 Definition 
Children with Hirschsprung's disease are missing the nerve cells (ganglion cells) 
within the wall of their colon or rectum. These cells are responsible for the normal wave-like 
motion of the bowel (peristalsis). When they are missing the stool stops and an obstruction 
occurs.the length of affected bowel varies. The most common transition point is in the upper 
rectum or the sigmoid colon. 
Hirschsprung's disease is a congenital disease. That means a person is born with it. 
The disease may also be hereditary, which means a parent can pass it to a child. 
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Symptoms 
Symptoms usually begin within a few days after birth. But some people don't develop 
them until childhood or even adulthood. 
In infants, the primary symptom is not passing meconium, an infant's first bowel movement, 
within the first 24 to 48 hours of life. Other symptoms include: 
 Vomiting and abdominal distention as a newborn 
 Chronic constipation 
 More rarely diarrhea, fever, and distention (symptoms associated with enterocolitis – 
inflammation of the small intestine and colon). 
Symptoms in older children include passing small watery stools, diarrhea, and a lack of 
appetite. 
Diagnosis 
The diagnosis is made by a combination of barium x-rays and rectal biopsy. In a 
lower GI series, x-rays are used to measure the width of the colon and rectum. Rectal biopsy 
involves removing a piece of rectal tissue to learn whether the nerve cells that control 
intestinal muscle contractions are present. Rectal manometry, a test that involves recording 
pressure changes within the colon and rectum, is sometimes performed. 
Treatment 
The treatment of Hirschsprung's disease is primarily surgical. The goal of surgery is 
to remove the abnormal bowel and attach the normal bowel to the anus just above the 
sphincter.  
Irritable bowel syndrome 
Definition 
Irritable bowel syndrome is a disturbance of bowel function that includes symptoms 
of abdominal pain or discomfort and altered bowel habit (change in frequency or 
consistency) – chronic or recurrent diarrhea, constipation, or both in alternation. IBS 
comprises a group of functional bowel disorders. 
"Irritable Bowel" refers to a disturbance in the regulation of bowel function that results in 
unusual nerve sensitivity and muscle activity. 
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Symptoms 
The symptoms of  IBS include abdominal pain or discomfort and changes in bowel 
habits. To meet the definition of IBS, the pain or discomfort should be associated with two of 
the following three symptoms: 
 Start with bowel movements that occur more or less often than usual 
 Start with stool that appears looser and more watery or harder and more lumpy than 
usual 
 Improve with a bowel movement 
Symptoms may often occur after eating a meal. To meet the definition of IBS, symptoms 
must occur at least once per week for at least 2 months. 
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DRUG REVIEW 
 
1.  CHUKKU - Rf;F  
Botanical Name  :  Zingiber officinale 
English Name             :    Dried Ginger  
 Family              :    Zingiberaceae 
P  used  Rhizome 
ORGANOLEPTIC CHARACTER 
Suvai :   Karppu 
Thanmai              :    Veppam 
Pirivu               :    Kaarppu 
nghJ Fzk; : 
Rf;F 
“#iyke;jk;  neQ;nrhpg;G NjhlNkg; gk;koiy 
%yk; ,iug;gpUky; %f;FePh;  - thyfg  
Njhljp rhue; njhlh;thj Fd;k ePh;j; 
Njhlk; Mkk;Nghf;FQ; Rf;F” 
                           (mfj;jpah;  Fzthflk;) 
ACTIONS: 
 Stimulant 
 Carminative 
 Stomachic 
CHEMICAL CONSTITUENTS:   
 Camphene  
 Phellandrene  
 Zingiberine  
 Cineol and Borneol  
 Gingerol 
 An Oleoresin-Gingerin 
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 Resins and starch 
 β-Sesquiphellandrene 
 Gingerdiols, Gingerdiacetates. 
                                                                         Ref:Indian Herbal Pharmacopoeia 
Articles on Zingiber officinale: 
Zingiber officinale natural gold: 
 It is consumed worldwide as a spice and flavoring agent and is attributed to have 
many medicinal properties. The British Herbal Compendium reported its action as 
carminative, anti- emetic, spasmolytic, peripheral circulatory stimulant and anti inflammatory 
.The oil of ginger is a mixture of constituents, consisting of monoterpenes (phellandrene, 
camphene, cineole, citral, and borneol) and sesquiterpenes (zingiberene, zingiberol, 
zingiberenol, ß-bisabolene, sesquiphellandrene, and others). Aldehydes and alcohols are also 
present  
Effect on gastrointestinal tract: Some active components of ginger are reported to 
stimulate digestion, absorption, relieve constipation and flatulence by increasing muscular 
activity in the digestive tract. It is also significantly reduced the nausea and vomiting. 
                                                                     International Journal of Pharma and Bio Sciences                            
                                                                        
http://ijpbs.net/volume2/issue1/pharma/_29.pdf 
 
Overview of pharmacodynamic data regarding the herbal substance(s)/preparation(s) 
including data on relevant constituents Gastrointestinal motility: 
Gastrointestinal motility  of zingiber officinalis in a placebo-controlled, double-blind, 
cross-over study in 12 male volunteers, Micklefield et al. [1999] reported that inter-digestive 
antral motility of the stomach during phase III of the migrating motor complex and the motor 
response to a test meal in the corpus measured by stationary manometry were stimulated by 
ginger (200 mg of ginger rhizome extract) in both the fasting and postprandial states. 
However, a randomised, placebo-controlled, cross-over study by Phillips et al. [1993] did not 
observe an impact on gastric emptying rate in 16 healthy volunteers using the oral 
paracetamol absorption technique (without an accompanying nutrient load) after 1 g (2 
capsules) of powdered ginger, suggesting that ginger, although increasing motility, may not 
affect the gastric emptying rate 
                        http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-         
                                       _HMPC_assessment_report/2012/06/WC500128140.pdf 
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2.  KADUKUROHINI   - fLFNuhfzp 
Botanical Name   :  Picorrhiza  scrophulariflora 
            English Name              :    Black Hellebore  
Family    : Scrophulariaceae 
            Part used               : Root 
 
ORGANOLEPTIC CHARACTER 
Suvai :   Kaippu, karppu 
Thanmai              :   Veppam 
Pirivu               :    Karppu 
 
nghJ Fzk; : 
fLFNuhfzp 
“khe;jQ; Ruikak; thAfug; ghdhkQ; 
Nrh;e;jkyf; fl;L jphpNjhlk; - Nghe;jnghl;Lg;  
Gz;tapW NehapitNghk; nghwnfhbNa – NgjpAz;lhk;  
jpz;fLF Nuhfzpf;Fj; Njh;” 
       (mfj;jpah;  Fzthflk;) 
CHEMICAL CONSTITUENTS:    
 Iridoid glycosides, 
 Picroside I 
 Kutkoside 
                                                                 Ref: Indian Herbal Pharmacopoeia 
ACTIONS: 
 Cathartic  
 Antiperiodic 
 Anthelmentic 
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Articles on Picorrhiza kurroa: 
International journal of pharmaceutical research and biopharmaceutical research  
 
  Bitter Glycoside of Picorrhiza  
    In general, bitters are the edible natural products mostly consumed before any normal 
meals to stimulate as well as enhance the appetite.However, the bitter glycosidase a class do 
possess almost similar activities like the bitters such as: digestive, stomachic and febrifuge. 
Therapeutically, the bitters have been found to exert their stimulant effects on the gustatory 
(i.e.related to the sense of taste) nerves located in the mouth and ultimately give rise to an 
improved gastric juice secretion in the stomach.The bitter glycosideshave been found not 
confined to the same chemical class, butthe most important ones amongst them essentially 
possess the pyran cyclopentane ring. A number of bitter glycosidesisolated from natural 
plants have been put into actual therapeutic practice, namely: Picrorhiza, Gentianand Chirata  
 
                                            Http://www.ijprbs.com/issuedocs/2013/8/IJPRBS%20285.pdf 
 
 
3. .KALI PAKKU--  
 
Botanical Name         :  Areca catechu 
            English Name :    Areca nut boiled tender 
Family                        :   Fabaeceae 
Part used  :   Seeds 
 
ORGANOLEPTIC CHARACTER 
 
Suvai   :   Thuvarpu 
Thanma  :   Veppam 
Pirivu   : Karppu 
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nghJ Fzk; :
  
 fspghf;F 
“fspg;ghf;Fj; jpd;wf;fhw; fz;lj;Jl; Nfhio  
nahspg;ghghff; fl;Lkp/ Jz;ik – jsph;g;ghd 
gpj;j mNuhrfk;Nghk; Ngjpkpf cz;lhFQ; 
rpj;j kfpo;r;rpAWQ; nrg;G”                
 (mfj;jpah;  Fzthflk;) 
CHEMICAL CONSTITUENTS:    
 Tannins 
 Catechin    
 Catechu tannic acid 
 Flavonoids 
 Flavonols-quercitrin 
 Quercitin 
                                                                         Ref: Indian Herbal Pharmacopoeia 
ACTIONS 
 Astringent 
 Stimulant 
 
Articles on Areca catechu: 
Areca catechu: A comprehensive pharmacological Study: 
The main constituents of the areca nut are carbohydrate, fats, fibre, polyphenol 
including flavonoids and tannins, alkaloids and minerals (IARC, 2004). The fatty acid 
constituents of the A. catechu nut oil are; lauric 19.5, myristic 46.2, palmitic 12.7, stearic 1.6, 
decanoic 0.3, oleic 6.2, linoleic 5.4, dodecenoic 0.3, tetradecenoic 0.6 and hexadecenoic 
7.2%. The chief component glycerides are 56% of fully saturated (trimyristin, dimyristins and 
lauromyristopalmitin); 30% monounsaturated disaturated (mainly hexadeceno-
lauromyristins) and 14% of diunsaturated-monosaturated (oleolinoleo-glycerides, mostly 
oleolinoleopalmitin).  
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 Areca is used for treatment of a mental disorder called schizophrenia and an eye 
disorder called glaucoma;it is also as a mild stimulant; and as a digestive aid. Some people 
used areca as a recreational drug because it speeds up the central nervous system. 
           http://www.journalcra.com/article/areca-catechu-comprehensive  pharmacological                                                           
 
4. .SEENTHIL – rPe;jpy;  
Botanical Name :  Tinospora cordifolia 
English Name :  Heart leaved moon seed, tinospora , Gulanchatinospora 
Family  :  Menispermaceae 
            used   
 
ORGANOLEPTIC CHARACTER 
Suvai                   :   Kaippu 
Thanmai             :   Veppam 
Pirivu                  :    Kaarppu 
CHEMICAL CONSTITUENTS:    
 Berberine  
 Cordifolioside,  
 Asesqueterpene, 
 Choline tinosporicacid 
 Cordioside 
                                         Ref: Indian Herbal Pharmacopoeia  
ACTIONS: 
 
 Stomachic 
 Mild diuretic 
 Antioxidant 
 Antispasmodic 
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Articles on Tinospora cordifolia: 
 Chemistry and medicinal properties of Tinospora cordifolia (guduchi): 
The stem of Tinospora cordifolia is one of the constituents of several ayurvedic 
preparations used in general debility, dyspepsia, fever and urinary diseases. The stem is 
bitter, stomachic, diuretic, stimulates bile secretion, causes constipation, allays thirst, burning 
sensation, vomiting, enriches the blood and cure.s jaundice. The extract of its stem is useful 
in skin diseases. The root and stem of T. cordifolia are prescribed in combination with other 
drugs as an anti-dote to snake bite and scorpion sting Dry barks of T. cordifolia has anti-
spasmodic, antipyretic, anti-allergic, anti-inflammatory and anti-leprotic properties. 
Indian Journal of Pharmacology 2003; 35: 83-91 educationaforum 
5.KATRALAI- : 
Botanical Name :  Aloe barbardensis 
English Name :  IndianAloe , Curacao aloe 
Family  :  Liliaceae 
Part used                                  
 
ORGANOLEPTIC CHARACTER 
Suvai                           :   Sirukaippu 
Thanmai  :  Thatppam 
Pirivu   :    Inipu 
 
CHEMICAL CONSTITUENTS:    
 Glycosides 
 Anthracenederivative 
 Hydroxyanthraquinonederivatives 
 Aloin 
                                                                            Ref : Indian Herbal Pharmacopoeia 
 
ACTIONS: 
Purgative 
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nghJ Fzk; : 
 fw;whio 
“nghy;yhNk fq;fgk;G Or;#iy Fl;lurk;  
my;yhh;kj; jk;gfe;j uq;Fd;kk; vy;yhk;tpl; 
NlF khpf;F nkhpr;rw; fphpr;ruK 
khF khpf;F kUz;L”                                     
        ( Njiuah; Fzthflk;) 
ARTICLES ON ALOE BARBARDENSIS: 
Evaluation of the Nutritional and Metabolic Effects of Aloe vera 
Laxative 
Aloe vera latex is commonly used in the treatment of constipation (de Witte 1993); 
The laxative effect of the anthraquinone glycosides found in Aloe vera latex is well 
established (Ulbricht et al. 2008). In a double-blind, randomized, controlled trial of 28 
healthy adults, aloin was reported to have a laxative effect compared to a placebo that was 
stronger than the stimulant laxative phenolphthalein (Chapman and Pittelli 1974). In subjects 
with chronic constipation, a novel preparation containing Aloe vera, celandine, and psyllium 
was found to improve a range of constipation indicators (bowel movement frequency, 
consistency of stools, and laxative dependence) in a 28-day double-blind trial; however, the 
effect of Aloe vera alone was not investigated in this study (Odes and Madar 1991). 
                                   Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition 
                                       http://www.ncbi.nlm.nih.gov/books/NBK92765/ 
 
6. KADUKAI-  
Botanical Name   :  Terminalia chebula 
English Name  :   Chebulin myrobalan 
Family   :   Combretaceae 
  Part used             
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ORGANOLEPTIC CHARACTER 
Suvai         :   Sirukaippu 
Thanmai :   Thatpam 
Pirivu   :    Inipu 
CHEMICAL CONSTITUENTS:    
 Tannin 
 Gallicacid 
 Chebulic acid 
Ref: Indian Herbal Pharmacopoeia 
nghJ Fzk;  
fLf;fha; 
“jhil fOj;jf;fp jhY Fwpaptplg; 
gPil rpypgjKw; NgjpKlk; - Milnal;lhj; 
J}ykpb Gz;thj Nrhzpfh khiyapuz; 
lhykpb Nghk;thpf;fh ahy;”. 
                                    (mfj;jpah;  Fzthflk;) 
ACTIONS: 
 Laxative 
 Purgative 
 Alternative 
Articles OnTerminalia chebula: 
Haritaki A Boon To Herbalism – A Review 
 Terminalia chebula (Haritaki) is one of the important herbal drug used for treating 
many diseases including some varieties of cancer. It is rich in chemical constituents. Many 
pharmacological investigations have been carried out based on its chemical 
constituents.itcontains high phenolic content, especially hydrolyzable tannins, anthraquinone, 
flavonol, carbohydrates, glucose and sorbitol , chebulic acid , chebulinic acid  ellagic acid, 
gallic acid , chebulagic acid  etc. 
Scholars Academic Journal of Biosciences (SAJB) 
http://saspublisher.com/wp-content/uploads/2014/03/SAJB-22132-136.pdf 
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Comparative laxative  evaluation for andrographis  paniculata and Terminalia chebula 
in experimental animal model 
 
Main objective of this study was the Comparative laxative activity evaluation for A. 
Paniculata &T.chebula in experimental animal model. Our experiment showed that boththe 
extracts of A.paniculata and T.chebula ability to increase the laxative activity in constipation 
condition. The Property of the herbal extract was determined by in vivo, its effect on faecal 
output in rats andThe results were shown when compared with standard drug Bisacody 
http://www.irjponline.com/admin/php/uploads/1690_pdf.pdf 
 
7. Sivathai -  
Botanical Name : OperculinaTurpethum 
English Name :  Turteth root  
Family  :  Convolvulaceae 
 Parts used                         
 
ORGANOLEPTIC CHARACTER 
Suvai                :   Kaippu 
Thanma           :  veppam 
Pirivu              :    Karppu 
   
nghJ Fzk; 
 ntz;rptij Nth;  
“cs;s kyKk; cjthh;j;j Kk;tapw;iwf; 
nfhs;Sgpj;j thjKk;Nghq; $Qq;fht;  - gps;isfl;Fr; 
nrg;G fpurKk;Nghe; NjNd Ayfj;Js; 
jg;gpy; rptijf;Fj; jhd;” 
                                  (mfj;jpah;  Fzthflk;) 
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CHEMICAL CONSTITUENTS:    
 Turpethin resin 4 to 10%,  
 Glucoside, 
 Turpethin 
                                                         Ref:Indian Herbal Pharmacopoeia  
ACTIONS: 
 Purgative  
 Immuno modulatory 
 Anti oxidant 
 
Articles   on  Operculina turpethum: 
Non-opiodergic like mechanism for antinociceptive analgesic and antipyretic activity of 
ethanolic root extract of operculina turpethum in swiss albino mice 
The root extract of Operculina turpethum has been used as an anti inflammatory, purgative, 
hepato-protective agent and antipyretic. 
International Journal of Pharma and Bio Sciences 
http://www.ijpbs.net/cms/php/upload/2108_pdf.pdf 
 Thus Sivathai having anti-infammatory and anti pyretic action  is helpful in the 
treatment of  Kattu mantham. 
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MATERIALS AND METHODS 
 Kattu Mantham is one of   the common functional GIT disorder in children. In our NIS 
OPD, 3-5% of cases are approaching Kuzhandhai Maruthuvam department daily with the 
Symptoms of  Kattu Mantham . Hence it was proposed to study about  the disease. A Protocol  
was prepared and submitted before IEC of  National Institute of Siddha .The IEC approval 
was obtained  No:NIS/IEC/18-14/20-18-26-08-2014. The trial was  registred in Clinical trial 
Registry of India with  Reg .No.CTRI/2016/04/006818 .After obtaining approval from  the 
committee, the clinical study on Kattu mantham ( Dyspepsia ) in  children with drug   Seenthil 
kudineer  and carried out as per the protocol.    
 In vitro Carminative activity were conducted in Satya bama university,Chennai and  
physico chemical activity studies of  Seenthil kudineer  were done  at  CRI,  Arumbakkam.                        
 After finishing the In vitro Carminative activity studies, 40 cases were selected from 
the OPD & IPD of Kuzhandhai Maruthuvam Department, National Institute of Siddha. They 
were treated with the trial drug with Seenthilkudineer and observed for prognosis clinically. 
 
PREPARATION OF SEENTHIL KUDINEER: 
  COLLECTION OF RAW DRUGS 
          The required drugs were purchased from a reputed  raw drug  shop at kanda swamy 
kovil street paris . 
AUTHENTICATION 
Raw drugs were authenticated by the Medicinal Botanist in National Institute of 
Siddha, Chennai. The test drug Seenthil kudineer was prepared at Gunapadam lab, National 
Institute of Siddha.Chennai-47 
.Purification Method:  
 Chukku              -  To  soak in chunnambu thelineer for 3 hours dried and to                        
         peel off  outer skin 
  Seenthil               -   To peel off  the outer skin.  
 Sivathai            -   To remove veins, boil in milk, dried it in sunlight 
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 Kadugurookini  -   To soak in neem leaves juice for three hours and dried it in 
sunlight. 
 Kadukai   -   To remove inner seeds. 
 Kalipakku               - soak in water and dried in sunlight 
 Katralai sarugu    -   remove thornes and dried  it  in sunlight 
                                                                              Sikicha Rathina Deeepam
 
Preparation of the Seenthil kudineer: 
Ingredients: 
Tinospora cordifolia (seenthil thandu)                      -     4 grams 
Araca catechu (kali pakku)                               -     4 grams 
Operculina terpethum (sivathai)                        -     4 grams 
Terminalia chebula (kadukkai)                           -    4 grams 
Zingiber officinalis  (sukku)                                -     4 grams 
Picrorhiza scrophulariflora (kadukurokini)      -    4 grams 
Aloe barbadence (katralai sarugu)                      -     4 grams 
                                                                      Ref  :  Balavagadam(pg 93) 
Method of preparation: 
 Above mentioned drugs were  purified by purification method mentioned below . All 
purified drugs are coarsely  powdered  and kept in a clean glass container . 
Method of preparing  Kudineer: 
             Above mentioned decotion powder ( 26 gms) was taken and  mixed with 80 ml   of 
water and boiled until one eigth of decoction. 
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Dosage : 10 ml b.i.d 
Drug Storage: 
 Prepared medicine in coarse   powder form will be stored in clean and dry container. 
Dispensing:   
Prepared medicine of  52 gms will be given as coarse powder form in separate  air 
lock covers. 
PHYSICO CHEMICAL ANALYSIS 
The physicochemical analysis of the test drug  Seenthil kudineer was carried out as 
per WHO guidelines (Anonymous 1998). The test procedures were done at Siddha Central 
Research Institute (CRI), Arumbakkam Chennai. Since the form of the drug is in powder  the 
parameters such as Loss on Drying at 105
o
C,Total ash,Acid insoluble ash Water soluble 
Extractive ,Alcohol Soluble Extrative,pH was done using Quality control methods for 
medicinal plants materials. 
Loss on drying of the sample at 105ºC 
4g of test drug was weighed in a previously weighed 100ml beaker and heated in an 
oven at 105ºC for 5hours. Cooled in a dessicator and weighed.  Repeated the procedure till 
constant weight was obtained.  The percentage loss in weight of the test drug was calculated 
by the following formula. 
 
Calculation: 
                                                                       Loss in weight of test drug 
Percentage of loss on drying at 105ºC   =   ------------------------------------------------ x 100 
                                                                       Weight oftest drug taken 
Ash content  
a. Total ash content  
 4g of test drug was weighed accurately in a previously ignited and tared silica dish.  
The material was evenly spread and ignited in a muffle furnace at 600⁰C until it became 
white indicating the absence of carbon.  The dish was cooled in a dessicator and weighed.   
As carbon free ash cannot be obtained in this manner, the dish was cooled and the residue 
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moistened with sufficient quantity of water.  Dried on a water bath and then ignited in the 
electric furnace to get the constant weight. Cooled the dish in a dessicator and then 
weighed. The percentage of total ash of air-dried materials was calculated as per the 
formula given below.  
Calculation: 
                                    Weight of the ash   
Percentage of total ash   =   --------------------------------- x 100 
                                Weight of test drug taken 
 
b. Acid-insoluble ash  
      The total ash of the test drug was found out as described above. To the dish 
containing the total ash was added 45 ml of 1: 5 hydrochloric acid in three portions of 13 ml 
each time.  Boiled gently for 5 minutes and filtered. Collected the insoluble matter on an 
ashless filter paper (Whatman No.41) and washed with distilled water until the residue was 
free from acid.  Transferred the filter paper containing the insoluble mater to the original 
dish.  Dried and ignited to the constant weight. Cooled the dish in a dessicator, and then 
weighed.  Calculated the percentage of acid-insoluble of the air-dried material by the given 
following formula. 
             Calculation: 
                                      Weight of the acid-insoluble residue   
Percentage of acid-insoluble ash   =   -------------------------------------------- x 100 
                                                                    Weight of test drug taken 
Extractive of the test drug 
a. Water-soluble extractive of the test drug 
       4 g of the test drug was weighed accurately in a glass stoppered flask. Added 100 ml of 
distilled water and shakened occasionally for 6 hours and then allowed to stand for 18 hours. 
Filtered rapidly taking care not to lose any solvent and pipetted out 25 ml of the filtrate in a 
preweighed 100 ml beaker and evaporated to dryness on a water bath. Kept in an air oven at 
105ºC for 6 hours.  Cooled in a dessicator and weighed.  Repeated the experiment twice, and 
taken the average value. The percentage of water soluble extractive was calculated by the 
formula given below. 
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Calculation: 
                                                                          Weight of the extract          100 
   Percentage of water soluble extract   =   -------------------------------- x --------- x 100  
                                                                         Weight of sample taken         25 
 
b. Alcohol-soluble extractive of the sample   
       4 g of the sample was weighed accurately in a glass stoppered flask. Added 100 ml of 
distilled alcohol (approximately 95%) and shaken occasionally for 6 hours and then allowed 
to stand for 18 hours.  Filtered rapidly taking care not to lose any solvent and pipetted out 25 
ml of the filtrate in a preweighed 100 ml beaker and evaporated to dryness on a water bath.  
Kept in an air oven at 105ºC for 6 hours and cooled in a dessicator and weighed.  
Repeated the experiment twice, and taken the average value. The percentage of alcohol 
soluble extractive was calculated by the formula given below. 
Calculation: 
                                                                       Weight of the extract               100 
 Percentage of alcohol soluble extract   =  ------------------------------- x ---------------  x 100  
                                                                     Weight of sample taken               25 
 
i. Determination of pH 
The pH of the Seenthil kudineer  was estimated as per the method prescribed in the 
Indian standard (IS) -6940(1982). The procedure was done at NIS, Chennai 47. 
 One gram of the testdrug was taken into a 100ml graduated cylinder containing about 
50 ml of water. The cylinder was  shaken vigorously for two minutes and the suspension was 
allowed to settle for hour at 25ºC  to 27ºC, then 25 ml of the clear aqueous solution was 
transfered in to a 50 ml beaker and tested for pH using digital pH meter . 
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5.1.2 Pharmacological activity 
In-vitro Carminative Activity 
Project ID  :  PSA/30/16-17 
Institute  :  National Institute of Siddha, Chennai, Tamil Nadu, India 
Sample Name  : SeenthilKudineer 
Sample ID   :  SK 
Preparation of Seenthil Kudineer Decoction 
   Decoction of the raw sample was prepared by extracting the crude drug with distilled 
water by using soxhlet extraction setup. The decoction thus collected will be used for the 
following estimation 
 
In-vitro Carminative activity acid-base titration technique 
In-vitro carminative activity of the SeenthilKudineer was evaluated by modified 
method of Swapnil Sharma et al. About 5, 10, 20 and 40 ml of the SK decoction were placed 
in conical flask fitted with air-tight nozzle, to this 100 ml of distill water was added. 
About 100 ml of NaOH {1M, previously standardized to oxalic acid} was poured into 
a plastic container fitted with aeration tubing system that was connected directly to the 
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reaction vessel containing varying volume of test sample (SK). The flask was agitated 
manually for the next 45 mins and was allowed to stand for overnight.The carbon dioxide gas 
evolved from the reaction vessel was allowed to pass into a plastic container containing 
excess sodium hydroxide where it was absorbed and converted into equivalent amount of 
sodium carbonate.The resulting mixture consisting of excess sodium hydroxide and sodium 
carbonate was titrated with standard HCl using phenolphthalein as indicator to get first 
endpoint and in continuation to this the second endpoint was enumerated using methyl orange 
as indicator. The difference in milliliters between the first & second endpoints was used to 
calculate the carbon dioxide content per gram of sample. 
Vol. of titrant x molarity of std. acid x mol. Wt. of CO2 = mass of CO2 in gm 
Molarity of the Acid is 0.0829M 
Mol. Wt. of CO2 is 44.01 g/mol 
Triplicate 1 
Volume of Test Sample Difference in Titration value 
(ml) 
Mass of CO2 in gm 
 
5 1.8 6.56 
10 2.4 8.75 
20 3.6 13.13 
40 4.6 16.78 
Triplicate 2 
Volume of Test Sample Difference in Titration value 
(ml) 
Mass of CO2 in gm 
 
5 2 7.29 
10 2.2 8.02 
20 3.3 12.03 
40 4.5 16.41 
Triplicate 3 
Volume of Test Sample Difference in Titration value 
(ml) 
Mass of CO2 in gm 
 
5 1.7 6.20 
10 2.4 8.75 
20 3.4 12.40 
40 4.2 15.32 
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Reaction Setup 
 
 
 
 
Evolvement of Carbon dioxide from the reaction mixture 
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5.1.3 Biochemical analysis 
Biochemical Analysis of Seenthil kudineer was done at the Biochemistry lab at 
National Institute of Siddha, Chennai by the method of Kolkate. 
Preparation of Extract: 
5ml of sample was taken in a 250ml clean beaker and added with 50ml of distilled 
water. Then it is boiled well for about 10 minutes. Then it is cooled and filtered in a 100ml 
volumetric flask and made up to 100ml with distilled water. This preparation is used for the 
qualitative analysis of acidic/basic radicals and biochemical constituents in it. 
5.1.3 Biochemical analysis 
Biochemical Analysis of Seenthil kudineer was done at the Biochemistry lab at 
National Institute of Siddha, Chennai by the method of Kolkate. 
Preparation of Extract: 
5ml of sample was taken in a 250ml clean beaker and added with 50ml of distilled 
water. Then it is boiled well for about 10 minutes. Then it is cooled and filtered in a 100ml 
volumetric flask and made up to 100ml with distilled water. This preparation is used for the 
qualitative analysis of acidic/basic radicals and biochemical constituents in it. 
Procedure: 
Test for Silicate 
A 2ml of the sample was shaken well with distilled water. 
Action of Heat: 
           A 2ml of the sample was taken in a dry test tube and heated gently at first and then 
strong. 
Action of Heat: 
           A 2ml of the sample was taken in a dry test tube and heated gently at first and then 
strong. 
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Ash Test: 
            A filter paper was soaked into a mixture of extract and dil. cobalt nitrate solution and 
introduced into the Bunsen flame and ignited 
I. Test for Acid Radicals 
Test for Sulphate: 
   2ml of the above prepared extract was taken in a test tube to this added 2ml of 4% dil 
ammonium oxalate solution 
 Test for chloride: 
 2ml of the above prepared extracts was added with 2ml of dil.HCl is added until the 
effervescence ceases off. 
Test for Phosphate: 
 2ml of the extract were treated with 2ml of dil.ammonium molybdate solution and 
2ml of con.HNo3. 
Test for carbonate: 
          2ml of the extract was treated with 2ml of dil. magnesium sulphate solution. 
Test for Nitrate: 
 1gm of the extract was heated with copper turning and concentrated H2So4 and viewed 
the test tube vertically down. 
II.Test for Basic radicals 
Test for lead: 
2ml of the extract was added with 2ml of dil.potassium iodine solution. 
Test for copper: 
 One pinch (25mg) of extract was made into paste with con. HClin a watch glass and 
introduced into the non-luminuous part of the flame. 
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Test for Aluminium: 
           To the 2ml of extract dil.sodium hydroxide was added in 5 drops to excess. 
Test for Iron:  
           a. To the 2ml of extract add 2ml of dil.ammonium solution  
           b. To the 2ml of extract 2ml of thiocyanate solution and 2ml of con HNo3 is added. 
Test for Zinc: 
 To 2ml of the extract dil.sodium hydroxide solution was added in 5 drops to excess 
and dil.ammonium chloride was  added.  
Test for Calcium: 
        To 2ml of the extract was added with 2ml of 4% dil.ammonium oxalate solution 
Test for Magnesium: 
        To 2ml of extract dil.sodium hydroxide solution was added in drops to excess. 
Test for Ammonium: 
 To 2ml of extract 1 ml of Nessler's reagent and excess of dil.sodium hydroxide 
solution are added. 
Test for Potassium: 
         A pinch (25mg) of extract was treated of with 2ml of dil.sodium nitrite solution and 
then treated with 2ml of dil.cobalt nitrate in 30% dil.glacial acetic acid. 
 Test for Sodium: 
         2 pinches (50mg) of the extract is made into paste by using HCl  and introduced into the 
blue flame of Bunsen burner. 
   Test for Mercury: 
         2ml of the extract was treated with 2ml of dil.sodium hydroxide solution. 
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Test for Arsenic: 
          2ml of the extract was treated with 2ml of dil.sodium hydroxide solution 
III. Miscellaneous 
Test for Starch: 
      2ml of extract was treated with weak dil.Iodine solution. 
Test For Reducing Sugar: 
       5ml of Benedict's qualitative solution was taken in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the extract and again boil it for 2 minutes. The colour 
changes are noted. 
Test for the Alkaloids: 
      a) 2ml of the extract was treated with 2ml of dil.potassium Iodide solution. 
      b) 2ml of the extract was treated with 2ml of dil.picric acid. 
     c) 2ml of the extract was treated with 2ml of dil.phosphotungstic acid. 
Test for Tannic Acid: 
 2ml of extract was treated with 2ml of dil.ferric chloride solution. 
Test for Unsaturated Compound: 
      To the 2ml of extract 2ml of dil.Potassium permanganate solution was added. 
Test for AminoAcid: 
      2 drops of the extract was placed on a filter paper and dried well. 20ml of Burette reagent 
is added. 
Test for Type of Compound: 
      2ml of the extract was treated with 2 ml of dil.ferric chloride solution. 
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5.2 CLINICAL STUDIES: 
Population and Sample:  
 
                The population consists of paediatric patients attending the OPD of   
AyothidossPandithar Hospital, National Institute of Siddha, Chennai-47.  
The sample consists of 1-3 years age group fulfilling any 3 of  the inclusion criteria 
and none of the exclusion criteria.  
 
Sample size: 40 Patients  
Study place: OPD &IPD of Ayothidosspandithar hospital,  
    National Institute of  Siddha, 
     Tambaram sanatorium, 
    Chennai – 46. 
 Inclusion criteria: 
Age 1 to 3  years 
Sex: Both male and female children. 
Children with minimum 3  clinical symptoms such as 
1. Indigestion 
2. Stomach pain 
3. Cough 
4. Fever 
5. Yawning 
6. Prespiration 
7. Constipation 
Exclusion criteria: 
1. Irritable Bowel Syndrome 
2. Childhood Asthma 
3. High temp >102oF 
4. Severe cough 
5. Intolerable stomach pain 
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Withdrawl criteria: 
1. Occurrence of any adverse effect 
2. Poor patient compliance &defaulters. 
3. Patient turned unwilling to continue in the course of clinical trial. 
4. Exacerbation of symptoms 
Study design       : An Open clinical trial.  
Study duration  : 12 Months 
Dosage of drugs  : 10ml (bid)  
Name of the trial drug :  Seenthil kudineer  
 
A.CLINICAL ASSESSMENT  
Clinical assessment  were done with reduction of following symptoms 
 Indigestion 
 Stomach pain 
 Cough 
 Fever 
 Constipation 
 
B.SIDDHA METHOD OF ASSESSMENT 
 Nilam 
 Kaalam 
 Uyirthathukkal 
 Udalthaathukkal 
 Envagaithervugal 
Study Enrollment: 
1.  In this study, patients reporting at the NIS OPD with the three or more clinical 
symptoms will be examined clinically for enrolling in this study based on the 
inclusion and exclusion criteria. 
2. The patients who are to be enrolled would be informed (Form VI) about the study, 
experimental medicine, possible outcomes and the objectives of the study in the 
language and terms understandable to them and to their informants. 
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3. After ascertaining the patient and informant willingness, informed consent would be 
obtained in writing from them in the consent form (Form II). 
 
4. All these patients will be given unique registration card in which patients‟ 
Registration number of the study, Address, Phone number and Doctors phonenumber 
etc. will be given, so as to report easily communication for the sake of the patient. 
 
5. Complete clinical history, complaints and duration, examination findings-- all would   
 be recorded in the prescribed Proforma in the history and clinical assessment 
 forms (form IV)  separately. Screening Form- I will be filled up; Form III  will be 
 used for recording the patients‟ history, clinical examination of symptoms and signs 
 respectively. 
    6.  Patient would be advised to take the trial drug and appropriate dietary advice              
 (Form X) would be given according to the patients‟ perfect understanding. 
 
Conduct of the Study: 
 The trial drug “SeenthilKudineer” is given for 1 day. For OP patients before and after 
treatment the clinical assessment will be done and prognosis is noted on 3
rd
 day.   For IP 
patients the drug is provided and prognosis is noted and clinical assessment will be done 
on 1
st
 day itself. 
   
Data Managment: 
               After enrolling the patient in the study, a separate file for each patient will be 
opened and all forms will be filed in the file. When study patient visits OPD during the study 
period, the respective patient file will be taken and necessary recordings will be made at the 
assessment form or other suitable form.The screening forms will be filed separately. 
The Data recordings will be monitored for completion and adverse event by HOD and 
data logical recording and completeness will be monitored by statistician (Sr.Research 
Officer (Statistics)).All forms will be further scrutinized in presence of Investigator by 
Sr.Research Officer (Statistics) for logical errors and incompleteness of data before entering 
onto computer to avoid any bias. No modification in the results is permitted for unbiased 
report. 
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Any missed data found in during the study, it will be collected from the patient, but 
the time related data will not be recorded retrospectively All collected data will be entered 
using MS access software onto computer.Investigator will be trained to enter the patient data 
and cross checked by SRO. 
Advese Effect/Serious Effect Management: 
If the trial patient develops any adverse reaction, he/she would be immediately 
withdrawn from the trial and proper management will be given in OPD of National institute 
of siddha and the same will be reported to regional pharmacovigilance center. 
Ethical Issues: 
1. No other external or internal medicines will be used.  
2. The data collected from the patient‟s informant will be recorded. The patient‟s 
 informant will be informed about the diagnosis, treatment and follow-up.  
3.  After the consent of the patient‟s informant (through consent form), patient will be 
 enrolled in the study.  
4. Informed consent will be obtained from the patient‟s informant explaining in the 
understandable language to the patient‟s informant. 
5. Treatment would be provided free of cost. 
6. In conditions of treatment faliure, adverse reactions, patients will be given             
alternative treatment at the National Institute of Siddha with full care. 
Data Collection Forms:- 
Form I        Screening & Selection Proforma 
Form II       Consent Form 
Form III      History Proforma 
Form IV      Assessment Form 
Form V       Drug compliance 
Form VI      Patient information sheet 
Form VII     Withdrawal 
Form VIII    Adverse reaction 
Form IX     Pharmaco vigilance 
Form  X     Dietary form 
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                                        6. RESULTS AND OBSERVATIONS 
 
Preclinical studies: 
Physicochemical analysis of Seenthil kudineer  
 
S.No. Parameters Results 
1 Loss on Drying at 105
o
c 10.27% 
2 TotalAsh 4.92% 
3 Acid insoluble Ash 0.53% 
4 Water soluble Extractive 20.55% 
5 Alcohol Soluble Extrative 15.20% 
6 pH 4.70 
 
Biochemical analysis of Seenthil Kudineer 
Results of Acid radicals studies 
S.NO Parameter Observation Result 
1 Test for Sulphate Cloudy appearance         
Present 
Positive 
2 Test for Chloride 
 
             -     
Negative 
3 Test For Phosphate 
 
            -  
Negative 
4 Test For Carbonate   
 
 
 
                   - 
 
          Negative                                                      
 
5 Test For Nitrate  
- 
Negative 
6 Test for Sulphide  
- 
Negative 
7 Test For Fluoride &oxalate 
 
 
- 
Negative 
8 Test For Nitrite 
 
                 - 
 
Negative 
9 Test For Borax 
 
- Negative 
 
Interpretation 
The acidic radicals test shows the presence of   Sulphate. 
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Results of basic radicals studies: 
S.NO Parameter Observation Result 
1 Test for Lead  
- 
Negative 
2 Test for Copper 
 
- Negative 
3 Test For Aluminium 
. 
Brown precipitate is 
formed 
Positive 
4 Test For Iron 
. 
- Negative 
5 Test For Zinc White precipitate is 
formed 
Positive 
6 Test for Calcium Cloudy appearance and 
white precipitate  present 
Positive 
7 Test For Magnesium 
 
White precipitate       
obtained 
Positive 
8 Test For Ammonium 
 
- 
 
Negative 
 
9 Test For Potassium 
 
- Negative 
10  Test For Sodium 
 
 
- 
 
Negative 
11 Test For Mercury 
 
 
- 
 
Negative 
12 Test For Arsenic 
 
 
- 
 
Negative 
 
Interpretation 
The basic radical test shows the presence of calcium, Aluminium, Zinc, Magnesium, and 
absence of heavy metals such as lead, Iron, arsenic and mercury. 
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Miscellaneous: 
S.NO Parameter Observation Result 
1 Test for Starch  
- 
Negative 
2 Test for Reducing sugars 
 
- Negative 
3 Test For Alkaloids 
. 
Yellow colour developed Positive 
4 Test For Tannic acid 
. 
Blue-black precipitate 
obtained 
Positive 
5 Test for unsaturated 
compounds 
 
- 
Negative 
6 Test for Amino acid                     - Negative 
7 Test For Type of compounds 
 
 Blue colour developed  Phenol cresol and 
hydroquinone are 
present 
 
Interpretation 
The Miscellaneous test shows the presence of Alkaloids, Tannic acid, Phenol cresol and 
hydroquinone  
 
In-vitro carminative Activity 
 Result Analysis 
The carminative profiling of the test sample SeenthilKudineer was evaluated on basis of the 
amount of cabondioxide evolved from the reaction mixture with varying volume of SK. The 
amount of cabondioxide {g} produced by the 5ml of the sample SKwas found to be (6.68 
±0.55),for 10 ml of sample it was (8.51 ± 0.42), 20 ml of sample it was (12.53 ± 0.53) and 40 
ml of sample it was (16.17 ± 0.75). 
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Volume of Test Sample Difference in Titration value 
(ml) 
Mass of CO2 in gm 
 
5 1.8 6.689 ± 0.55 
10 2.3 8.513 ± 0.42 
20 3.4 12.53 ± 0.53 
40 4.4 16.17±0.75 
 
Each value represents the mean ± SD. N=3 
Clinical Studies 
40 Patients with confirmed diagnosis of with satisfying the inclusion criteria were 
enrolled after obtaining written informed consent and were to receive Seenthil kudineer with 
dosage of 10 ml bid for 1 day 
Results were observed with respect to the following criteria: 
1. Age 
2. Sex          
3. Parent‟s Socio Economic Status    
4. Diet 
5. Nilam 
6. Paruvakaalam 
7. Uyirthathukkal 
8. Ezhuudalkattugal 
9. Envagaithervugal 
10. Neikuri 
11. Clinical features 
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Table1. Distributions of patients with Kattu Mantham according to Age  
S.NO AGE NO.OF.CASES PERCENTAGE% 
1. 1-2 Years 22 55 
2. 2.-3Years 18 45 
 
 
 
Inference: 
 Out of 40 patients, 55 % of cases were within 1-2years, 45 %  of cases were within 2-
3 years. (Table1) 
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Table 2.Distributions of patients with Kattu mantham according to Gender 
S.No Sex No of Cases Percentage% 
1. Male Child 25 62.5 
2. Female Child 15 37.5 
 
Inference: 
Out of 40 patients 62.5% were male children and 37.5% were female children. (Table 2) 
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Table.3. Distribution of patients with Kattu mantham according to socio-economic 
status 
S.No 
Socio-economic 
Status 
No of Cases Percentage% 
1. High Income group 5 12.5 
2. 
Middle Income 
group 
32 80 
3. Poor Income group 3 7.5 
 
 
Inference: 
About 7.5 % patients were under lower income group, 80% patients were under 
middle income group and 12.5% patients were under high income group.  The highest 
incidence occurred in middle income group.(Table 3). 
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Table 4.Distribution of patients with Kattu mantham according to Diet reference 
S.NO         FOOD HABITS             NO OF CASES     PERCENTAGE% 
1. Vegeterian                     3           7.5       
2. Non-Vegeterian                     37            92.5           
 
 
 
 
 
Inference: 
 According to diet, Vegeterian 7.5%, Mixed 92.5% were noted. (Table 4) 
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Table.5. Distribution of patients with Kattu mantham according to Nilam 
Nilam No of cases Percentage% 
Kurinji  0 0 
Mullai  0 0 
Marutham  2 5 
Neithal  38 95 
Paalai  0 0 
 
 
Inference: 
Among 40 patients, 95 % were from Neithal land,5 % from Marutham land, 0 % from Mullai 
land, and 0% from Kurinji land.(Table 5) 
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Table.6. Distribution of patients with Kattu mantham  according to Paruvakalam 
S.No Paruvakaalam No. of cases Percentage 
1. Karkaalam (Avani – puratasi) 1 2.5 
2. Koothirkaalam (Iyppasi – karthikai) 1 2.5 
3. Munpani (Markazhi – Thai) 11 27.5 
4. Pin pani (Masi – Panguni) 26 65 
5. Elavenil (Chitirai, Vaigasi)              1 2.5 
6. Mudhuvenil (Aani, Aadi) 0 0 
 
 Inference: 
According to paruva kaalam, high incidence of cases 65% were reported in Pinpanikalam 
,27.5% cases were reported in Mun pani kalam, 2.5% cases were reported in elavenil kaalam 
and 2.5% were from Karkalam,2.5% from karkalam and 2.5% from koothirkalam .(Table 6) 
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Table7a. Distribution of patients with Kattu mantham according to derangement of 
Vatham 
 
 
 
 
Inference: 
According to vatham, derangement of Pranan was 0%, Abanan was 100%,Viyanan 
was 100% ,Udhanan was 70% samaanam was affected 100 % and Kirukaran was deranged in 
100% and devathathan was 100% (Table 7a). 
SNO VATHAM NO OF CASES PERCENTAGE% 
1. Piranan 0 0 
2. Abanan 40 100 
3. Viyanan 40 100 
4. Uthanan 28 70 
5. Samanan 40 100 
6. Nagan 0 0 
7. Koorman 0 0 
8. Kirukaran 40 100 
9. Devathathan 40 100 
10. Thananjeyan 0 0 
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Table 7b. Distribution of patients with Kattumantham according to derangement of 
Pitham 
S.No Types of pitham No.of Cases Percentage 
1. Analapitham 40 100 
2. Ranjagam 4 10 
3. Saathagam 0 0 
 
4. 
Prasagam 
  0 
                 0 
5. Alosagam 0 0 
 
 
 
Inference: 
According to Pitham, derangement of Analapitham was 100%and Ranjagam was 10% 
(Table 7b). 
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Table7c. Distribution of patients with kattu mantham according to dearrangement of 
Kabam 
S.No Types of Kabham No.of Cases Percentage 
1. Avalambagam                40 100 
2. Kilethagam 40 100 
3. Pothagam 0 0 
4. Tharpagam 0 0 
5. Santhigam 0 0 
 
 
 
Inference: According to Kabam, derangement of Avalambagam was deranged in 100% 
of cases  and  Kilethagam was  affected in 100% cases  (Table7c). 
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Table8. Distribution of patients with Kattu mantham according to derangement of Ezhu 
Udarkattugal 
S.No Udarkattugal No.of Cases Percentage 
1. Saaram 40 100 
2. Senneer 4 10 
3. Oon 0 0 
4. Kozhuppu 0 0 
5. Enbu 0 0 
6. Moolai 0 0 
7. 
Sukkilam  / 
Suronitham 
 
0 
 
                 0 
 
Inference:  
Saram was affected in 100% of cases and Seneer was affected 10%   (Table 8). 
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Table9. Distribution of patients with Kattu mantham according to derangement of Enn 
vagai thervugal 
S.No Enn Vagai Thervugal Percentage% 
1 Naa 10 
2 Niram 10 
3 Mozhi 0 
4 Vizhi 10 
5 Sparisam 15 
6 Malam  100 
7 Moothiram 10 
8 
Naadi 100 
 
 
Inference: 
Out of 40 cases Malam was affected in100% of cases, Sparism was affected in  15% 
of cases ,Naa and Vizhi  was affected in 10% of the cases.(Table 9). 
Inference (Naadi): 
In Naadi, Vathapitham was observed in 50 % of cases, Pithavatham was observed in 
50 % of cases 
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Table10. Distribution of patients with Kattu mantham according to observation of 
Neikuri analysis 
S.No 
Character of 
urine 
Neikuri 
Reference 
No.of Cases Percentage 
1. 
Spreads like 
snake 
Vatha Neer 
20 
50 
2. 
Spreads like 
ring 
Pitha Neer 
17 
42.5 
3. Static as pearl Kaba Neer 3 7.5 
 
 
 
Inference 
According to Neikuri, Vatha neer was observed in 50   % of cases, pitha neer was 
observed in42.5 % of cases, Kaba neer was observed in 7.5 % of cases.(Table 10) 
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Table – 15  Distribution of clinical symptoms of Kattu mantham 
 
 
 
Inference 
Among the 40 cases, 100% of the patients   have constipation, 75% have abdomen pain, 70% 
have Indigestion ,15% have fever,  70% have cough and 35% have yawning  
 
 
S.No Signs and Symptoms 
No.of cases (out of 
40) 
Percentage 
1 Constipation 40 100 
2 Indigestion 28 70 
3 Abdomen pain 30 75 
4 Fever 6 15 
 
 
5 Yawning 14 35 
 
 
6 Cough 28 70 
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Table – 16  Results.  
Table11. Distribution of patients with Kattu mantham according treatment results 
obtained 
Clinical Features 
Before 
Treatment 
Percentage 
(%) 
After 
treatment 
Percentage (%) 
Constipation 40 100 15 37.5 
Indigestion 28 70 10 25 
Fever 6 15 2 5 
Abdomen pain 75 30 8 20 
Cough 28 70 8 20 
Yawning 14 35 4 10 
  
 
Inference: 
Out of the 40 cases, the signs and symptoms like constipation 100 %, indigestion 
70%,fever 15%,abdominal pain 30%,cough 70%,yawing 35% were reduced into37.5%, 25%, 
5%, 20%, 20%, 10% reduced respectivitly . These results were based on the clinical 
improvements observed. 
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For clinical studies 
Stastical analysis: 
 All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. STATA software was used to perform statistical analysis. 
Basic descriptive statistics include frequency distributions and cross- tabulations were 
performed. Bar diagram, Pie charts were used to describe the value of different variables for 
pictorial representation. The quantity variables were expressed as Mean and standard 
deviation and qualitative data as percentage. A probability value of less than 0.05 was 
considered to indicate as statistical significance. Paired„t‟ test was performed for determining 
the significance between before and after treatment. 
Clinical Symptoms score before and after treatment 
Treatment Mean ± Std Dev 95% of C.I Significance (t, p) 
Before (40) 0.533 4.479 t-value=23.9075 
p<0.001 After (40) 0.952 1.320 
 
                The mean and standard deviation of Before and After treatment were 0.533 and 
0.952  respectively .Which is statistically significant t-value =23.9075 p value p<0.0001 
                  The reduction of clinical symptoms after the treatment is significant  . The 
reduction in the symptoms is 65 % from the start of the treatment. 
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7. DISCUSSION 
 Kattumantham is a Functional Dyspepsia . It  is defined as persistant or recurrent pain 
or discomfort centered in the abdomen , without evidence or organic disease. Functional 
dyspepsia   is the most commonest health problem encountered in primary care worldwide, 
present about 80% of paediatric population. 
 Preclinical studies 
 Biochemical analysis 
The Bio chemical analysis of trial medicines showed shows presence of calcium, 
magnesium ,aluminium  ,sulphate ,zinc, alkaloids phenol, hydro quinine and tannic acid  
Presence of tannic acid – drug  containing  tannins posses anti ulcer activity ,it reduce 
symptoms of dyspepsia 
Presence of calcium – calcium ions significantly increase the drug release .it enhance the 
drug to absorb well. 
Physicochemical analysis: 
 physic-chemical analysis was done as preliminary evalution of   Seenthil kudineer  
.The method of measuring the moisture content in soild or semi-solid materials is loss on 
drying at 105 C
0
 was found to be it falls in between the limit range(1-20%)  The method of 
measuring the moisture content in solid materials is loss on drying (LOD) .Low moisture 
content is always desirable for higher stability of drugs. In Seenthil kudineer showed Loss of 
drying at 105C
0
  was found to be 10.27 % it falls in between the limit range( 1-20%).so the 
moisture content shows the good stability of the drug Seenthil kudineer  
 The ash value represents the purity of the drugs.The total ash includes both 
physiological ash, which is derived from the organic matter, and non physiological ash which 
is the residue of the extraneous matters like sand/soil, inorganic materials. The non 
physiologic ash is represented by acid soluble ash .The total ash in Seenthil kudineer  found 
to be 4.92% and the acid insoluble ash  to be 0.53%. The both ash value were under limits. 
The minimal level of acid insoluble ash shows the less inorganic residue and purity of the 
Seenthil kudineer . 
 The extractive values helps to indicate the nature of chemical constituents present in 
the drug. The water soluble substance is polar in nature and the alcohol has the ability to 
dissolve non-polar substance .The water soluble extract value of Seenthil kudineer  is 20.55% 
80 
 
and the Alcohol soluble extractive is 15.20 %  its shows the possibility of water  soluble 
constituents such as tannins, sugars, plant acids and mucilage, and alcohol soluble substance 
such as tannins, resins, and alkaloids to be present in the drug. As the drug Seenthil kudineer  
having more water soluble constituents than alcohol soluble, it would be non polar .So the 
trial drug shows good absorption & intracellular distribution without possible of 
accumulation inside the cells. The good water solubility may rapid the drug absorption and 
action. 
 Strongly acidic nature of the drug can cause the harmful effects to the body .so the 
screening for the pH is important for the drug .It represents the chemical nature of the drug 
and the site of absorption of non polar drug. The pH of Seenthil kudineer is found to be 4.70 
that is weakly acidic and safe in pH. The weakly acidic drugs are rapidly absorbed from 
stomach. So the trial drug Seenthil kudineer can act rapidly on oral administration. 
 
In vitro carminative  activity of Seenthil kudineer 
In-vitro carminative activity of the SeenthilKudineer was evaluated by modified method of 
Swapnil Sharma et al clearly indicates the test drug Seenthil kudineer (SK) The carminative 
profiling of the test sample SeenthilKudineer was evaluated on basis of the amount of 
cabondioxide evolved from the reaction mixture with varying volume of SK. The maximum  
amount of cabondioxide {g} produced by the 20ml of the sample SKwas found to be (12.53 ± 
0.53) and 40 ml of sample it was (16.17 ± 0.75) . 
 
CLINICAL REVIEW 
 Age: 
In the present study, Out of 40 patients, 62.5%  of cases were within 1-2 years, 37% were  
within 2-3 years. 
 Sex: 
   Out of 40 patients 62.5% patients were male children and 37.5 % patients were female 
children. Male children affected more than female children. 
 Socio-economic status: 
  About 7.5% patients were under lower income group, 80% patients were under middle 
income group and 12.5%  patients were under high income group.  The highest incidence 
occurred in middle income group. 
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 Seasonal variation:  
 According to Paruvakalam high incidence of cases 65% were reported in pin pani 
kaalam and 2.5% were reported in elavenil kaalam and 27.5% were reported in Munpani 
kaalam 2.5%  in kar kalam and 2.5% in koothir kalam . 
 Food habits: 
 According to food habits 7.5% had vegetarian diet  92.5% had mixed diet The highest 
incidence of cases was observed in mixed diet  
 Nilam: 
Among 40 patients, 95% were from Neithal land, 5% from Marutham land. 
 Vali (Vatham) 
Due to the derangement of   vatha the following symptoms occur. Abanan was 
affected  in  100 % of cases and cause constipation . Viyanan  was affected in 100% of cases.  
Samanan was affected in 100%  cases  and cause  poor appetite.Uthanan was affected in 70% 
of cases and cause cough , Kirukaran was affected in 100% and cause cough and Poor 
appetite and devathathan  was  affected  in  100%  and cause general body weakness. 
 Azhal (Pitham) 
Due to the derangement of Pitham the following symptoms occur. Analapitham was  
affected in 100% of cases and cause poor appetite and ranjagam was affected in 10 % of 
cases and cause anemia  . 
 Iyyam (Kabam) 
Deranged avalbagam was in 100% of cases,  Klethagam was affected 100 % of cases 
cause poor appetite . 
 Ezhu udarkattugal 
In Ezhu udal kattukal, Saram was affected 100% and due to  Cough, Poor 
appetite.Senneer was affected in 10% of cases due to anemia. 
 Envagai thervugal 
According to this study  
Malam was affected in 100% of cases. 
            niram was affected in 10% of cases  
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            Vizhi was affected 10% of cases 
             Moothiram was affected 10% of cases 
Sparisam was affected in 15% of cases (Low grade fever) 
 Naadi: 
 Vathapitham was observed in 50 % of cases 
              Pithavatham was observed in 50% of cases 
Accordingto naadi, high Distribution observed in vali Azhal, Azhal vali naadi. In 
siddha literature, the character of vali Azhal is due to poor appetite, indigestion and nausea. 
 Neerkuri 
Regarding moothiram, neerkuri showed straw coloured urine in all cases. 
 Neikuri 
In the present study, 50% of patient had vatha neikuri, 42.5% was observed as pitta 
neikuri and 7.5 % was observed as Kaba neikuri .According to this neikuri, vatham was 
dominately affected. 
Clinical features: 
The clinical feature of  kattumantham  may be correlate with general clinical manifestations 
of Dyspepsia In accordance with the clinical features of kattumantham Among the 40 cases, 
100% of the patients  have constipation , 75% have abdomen pain,70% have Indigestion and 
70 % have cough, 15% have fever and 35% have yawning 
Improvement in clinical features: 
       Regarding the symptoms,. Out of the 40 cases, the signs and symptoms like constipation 
100 % , indigestion 70%, fever 15%, abdominalpain 30% ,cough 70%, yawing 35% were 
reduced into 37.5% ,25% ,5%, 20% ,20%, 10% reduced respectivitly . These results were 
based on the clinical improvements observed  
                The mean and standard deviation of Seenthil kudineer before and after treatment 
were 0.533 and 0.952  respectively .Which is statistically significant t-value =23.9075 p value 
p<0.0001 
                  The reduction of clinical symptoms after the treatment is significant. The 
reduction in the symptoms is 65 % from the start of the treatment. 
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8. SUMMARY 
 The disease Kattu mantham  was taken for the clinical study with Seenthil kudineer after 
scrutinizing by the Screening committee of National Institute of Siddha.   
 The   Clinical studies were carried out after obtaining proper permission from approval 
IEC of National Institute of Siddha (No:NIS/IEC/18-14/18-26-08-2014). 
 The trial registred in Clinical trial Registry of India with Reg .No.CTRI/2016/04/006818 
was obtained. 
 The Authentication of ingredients of the trial drug was done obtained from Medicinal 
Botanist, National Institute of Siddha, Chennai.  
 Purification of raw drugs and preparation of trial drug was done at Gunapadam 
Laboratory, Department of Gunapadam, NIS Chennai.  
 Biochemical Qualitative analysis of trial drug was done in Biochemistry laboratory, 
Department of Biochemistry, National Institute of Siddha, Chennai. 
 Physicochemical analysis of Seenthil kudineer  was done in CRI Arumbakkam,Chennai 
 In- vitro carminative Activity of trial drug was done in Satya Bama University,Chennai 
 All the 40 patients, were treated in OPD  of Kuzhandhai Maruthuvam department at 
Ayothidoss Pandithar Hospital of National Institute of Siddha.  
 The patients with Kattu mantham were recruited based on Inclusion and Exclusion criteria 
and a detailed study was done. Separate proforma was maintained for each patient along 
with progress chart to monitor the prognosis.   
 The mean and standard deviation of Seenthil kudineer before and after treatment were 
0.533 and 0.952  respectively .Which is statistically significant t-value =23.9075 p value 
p<0.0001 
 The result shows 65% reduction in the clinical symptoms of patients after treatment and 
thus proves the efficacy of the medicine 
 The physicochemical analysis showed the trial drug is in appropriate consistency for trial 
study .  
 The patients have not complained of any adverse effects or difficulties during the course of 
treatment. Thus the drug is found to be safe and effective in the management of Kattu 
mantham.  
 The clinical efficacy of the drug was analyzed statistically on all the symptoms mentioned 
in the assessment criteria.The observation made during the clinical study showed that the 
trail drug Seenthil kudineer  was clinically effective. 
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9.CONCLUSION 
 The Siddha system of medicines has certainity with safer medications to treat 
children. 
The present study indicates the purity and stability of the  Seenthil kudineer .The 
result of  In –vitro  Carminative  Activity  of  Seenthil kudineer  possess promising 
Carminative  property.   
       The trial drug Seenthilkudineer  is treated to the  children of age group,1-3 years who are 
all diagnosed to have kattu mantham.The ingredients of  Seenthilkudineer are feasible and  
these  compounds  may serve as potentially useful drug at lower cost since most of them had 
carminative, laxative activity which controls kattu mantham. 
Clinical results were found to be  significant.  Good improvement was   found   in  65% of 
cases . 
The present clinical study   has established that Seenthilkudineer is having good result in 
reducing the majority of the symptoms of kattumantham..This has in turn provided a further 
research and opportunity for new drug established in the management of Kattu Mantham. 
Because of the  encouraging  result of above study, the drug  Seenthil kudineer may be taken 
for larger study in treatment of   Kattumantham.  
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ANNEXURES 
NATIONAL INSTITUTE OF SIDDHA, 
AYOTHIDOSS PANDITHAR HOSPITAL,  CHENNAI – 600 047. 
                      DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL   EVALUATION OF SEENTHIL KUDINEER    A SIDDHA DRUG  IN   THE 
TREATMENT     OF    KATTUMANTHAM   (DYSPEPSIA)   IN CHILDREN. 
                                                   SCREENING FORM -I 
1.  S.L No:       2. OP/ IP No:                           3.Name:          
4. Age:                  5.Gender:       6.Date of Enrollment:   
7.  Date of completion:              8.Informant:                  9.Reliablity:  
 
INCLUSION CRETERIA:                          YES        NO 
Age: between   1 - 3 years 
Constipation   
Indigestion        
Abdomen pain        
Fever(below 102
o
F)    
.  Cough   
             Yawning     
EXCLUSION CRITERIA  
High temp > 102F  
Botulism 
Hirsch sprung   disease 
Irritable bowel syndrome 
Severe vomiting 
 ADMITTED IN STUDY           
           If YES                                           OPD                             IPD 
 
SL   NO OF THE PATIENT                   O____                            I ____  
 Signature of Lecturer:                                                                                                                                               
Signature of HOD: 
                                                                                             Signature of Principal Investigator:  
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                                         NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
              A CLINICAL EVALUATION OF SEENTHIL KUDINEER FOR KATTU 
MANTHAM IN CHILDREN 
CONSENT FORM –II   
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the parent/guardian 
Signature  _________________ 
Date   _________________ 
Name  ________ _________ 
CONSENT BY PARENT 
 I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial, and the nature of drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my son/daughter body functions. 
 I am aware of my right to opd my son/daughter out of the trail at any time during the 
course of the trail without having to give the reasons for doing so.  
I, exercising my free power of choice, hereby give my consent to include my 
son/daughter as a subject in the clinical trial of „seenthil kudineer‟ for the treatment of kattu  
mantham  
Date :       Signature  __________________ 
      Name   __________________ 
Date :       Signature of witness Name _______________ 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
                                DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A CLINICAL EVALUATION OF SEENTHIL KUDINEER A SIDDHA DRUG IN 
THE TREATMENT OF  KATTU MANTHAM (DYSPEPSIA) IN CHILDREN 
Form III- CASE REPORT FORM 
1. HISTORY TAKING                                                                                 
Demographic data 
 SL No : OP/IP No. Visit Date : (__/__/____) 
Name :  
Age    :  
Gender                Male             Female Date Of Birth : (__/__/____) 
Father/ Mother /Guardian Name : 
 
 
Fathers Occupation : 
 
 
Fathers Monthly  Income : 
 
 
Religion : 
 
 
 
Socioeconomic Status : 
 
 
Patient Informant : 
 
 
 
Postal Address 
 
 
Contact No.  
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1.COMPLAINTS AND DURATION:           
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
--------------- 
2. PRESENT ILLNESS : 
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
--------------- 
 
3. HISTORY OF PAST ILLNESS: 
      ------------------------------------------------------------------------------------------------------------ 
     ------------------------------------------------------------------------------------------------------------ 
     ------------------------------------------------------------------------------------------------------------ 
 
4. FAMILY HISTORY: 
Any Hereditary/ Familial Disease     Yes                      No 
 If Yes, Details -------------------------------------------------------------------------- 
  
5. IMMUNIZATION HISTORY:  
 Immunization   complete          Incomplete         Complete but time lag 
 
6. FOOD HABITS: 
1. Veg  2. Non-Veg  3. Mixed 
 
7. GENERAL EXAMINATION: 
1. Pallor    YES  NO 
2. Jaundice   YES  NO 
3. Cyanosis   YES  NO 
4. Clubbing   YES  NO 
5. Pedal oedema   YES  NO 
6. Lymph adenopathy  YES  NO 
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8. VITAL SIGNS : 
1. Pulse rate / min            - 
2. Heart rate / min               - 
3. Respiratory Rate / min    - 
4. Temperature                     - 
ANTHROPOMETRY:- 
          Height    -                        
          Weight   - 
            CLINICAL EXAMINATION:                  
  ALIMENTARY  SYSTEM 
A )INSPECTION: 
Shape of the Abdomen     :  Distended  / Scaphoid 
Scars                                 :   Present     / Absent  
Umbilicus                         :   Inverted   /  Everted 
Visible veins                     :   Present    / Absent 
Peristaltic waves              :   Present    / Absent 
 b)   PALPATION: 
Tenderness                        :   Present    / Absent 
Palpable mass                   :   Present    / Absent 
Enlargement                     :   Present    / Absent 
c)    PERCUSSION: 
Shifting dullness              :   Present    / Absent 
Fluid Thrill                      :   Present    / Absent 
 
d)   AUSCULTATION: 
   Bowel sounds              : Absent/ Normal / Increased / decreased______________ 
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Other systems:                     
Cardio vascular system    : Normal             Affected 
Gastro intestinal system   : Normal             Affected 
Musculo skeletal system : Normal             Affected 
Central nervous system    : Normal             Affected 
Endocrine system             : Normal            Affected 
                                     SIDDHA ASSESSMENT 
Nilam:-  
Kurinji  Mullai  Marutham      Neithal   Paalai 
Kaala Iyalbu:-  
 Kaarkalam    Koothirkaalam  Munpanikaalam  
 Pinpanikaalam            Illavenirkaalam          Muthuvenirkaalam 
Yaakai:- 
 Vatham          Vatha Pitham           Vatha Kabam 
 Pitham    Pitha vatham   Pitha Kabam 
 Kabam             Kaba Vatham   Kaba Pitham 
Gunam  
 Sathuvam   Rasatham   Thamasam 
Pori / Pulangal 
  Normal Affected      Remarks          Normal Affected      Remarks 
Mei / unarvu 
Vaai / suvai  
Kan / parvai  
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Mooku / natram 
Sevi / olli 
Kanmendhirium / Kanmavidayam 
   Normal     Affected       Remarks       Normal      Affected         
Kai / dhanam 
Kaal / ghamanam 
Vaai / vaaku 
Eruvai / visarkam 
Karuvai / anantham 
Uyir Thathukkal 
Vatham:                    Normal            Affected Remarks 
Pranan                            
Abanan 
Viyanan  
Uthanan 
Samanan 
Nagan  
Koorman 
Kirukaran  
Devathathan   
Dhanajeyan                     
   
Pitham:             Normal         Affected    Remarks 
Analam  
Ranjagam    
Saathagam   
Alosagam  
Prasagam 
95 
 
Kabam :                   Normal           Affected Remarks 
Avalambagam    
Kilethagam   
Pothagam  
Tharpagam   
Santhigam  
 
Udalthathukkal 
   Normal Affected         Remarks 
Saaram 
Senneer  
Oon  
Kozhuppu 
Enbu 
Moolai 
Sukilam / Suronitham   
Envagai Thervugal  
                            Normal  Affected  Remarks 
Naa  
 Niram 
           Thanmai 
 Suvai 
 
Niram 
   
Mozhi   
Vizhi  
 Niram 
 Thanmai 
 Paarvai 
 
Sparisam  
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Malam 
 Niram   Normal Affected 
 Nurai   Normal Affected 
 Elagal   Normal Affected 
 Erugal   Normal Affected 
Moothiram 
 Neerkuri:       Niram   Normal Affected 
  Edai   Normal Affected  
  Nurai             Normal  Affected 
  Manam            Normal  Affected  
  Enjal      Normal Affected   
Neikuri: 
  Vatham  
  Pitham 
  Kabam          
  Others 
Naadi: 
 
Date  : ___________________     Station : ___________________ 
             
Signature of the Investigator: 
 Signature of the Lecturer: 
Signature of the HOD:  
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                                     NATIONAL INSTITUSTE OF SIDDHA, 
     AYOTHIDOSS PANDITHAR HOSPITAL,  
                                        CHENNAI  – 600 047. 
                      DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
                                    FORM IV –CLINICAL ASSESSMENT FORM 
CLINICAL EVALUATION OF   SEENTHIL KUDINEER    A  SIDDHA  DRUG  IN   
THE   TREATMENT     OF    KATTUMANTHAM   (DYSPEPSIA)   IN CHILDREN. 
1.  S.l. No:    2. OP/ IP No:                           3.Name:          
4. Age:               5.Gender:   6.Date of Enrollment:   
7.  Date of completion:           8.Informant:   9.Reliablity 
 
SL.NO.  
 
Clinical Features   1
ST
 DAY  2
ND
 DAY  3
RD
 DAY 
1  Constipation    
2 Consistency    
3 Abdominal Pain     
4  Fever    
5 Indigestion    
6  Cough    
7 Yawning    
 
                                                                                                            Signature of the 
Investigator: 
 
 Signature of the Lecturer: 
Signature of the HOD:  
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A CLINICAL EVALUATION OF SEENTHIL KUDINEER FOR KATTU                      
MANTHAM  IN CHILDREN 
                                                FORM V – DRUG COMPLIANCE   
1. S.l. No: 2. OP/ IP No  : 3. Name: 
4. Age: 5. Gender   : 6. Date of Enrollment: 
7. Date of completion: 8. Informant : 9. Reliablity: 
 
NAME OF THE DRUG  SEENTHIL KUDINEER 
FORM OF THE DRUG    Coarse powder 
ADMINISTRATION         PER ORAL 
DOSE & DURATION        10ml  (BD)FOR 1 DAY 
NO. OF DRUG POCKET GIVEN  56 GMS 
NO. OF DRUG POCKET RETURNED     
 
DAY DATE 
OF          
DRUG    
INTAKE 
MORNING 
  
EVENING  
  
   
DAY 1     
 
Date: 
Station:   
 
   
Signature of Principal Investigator: 
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FORM VI  PATIENT INFORMATION SHEET 
 
Name of Principal Investigator       :______________________________ 
Name of the institute                        : National Institute of Siddha, 
                                                     Tambaram Sanatorium, 
                                                     Chennai-47. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL. 
 
I, ________________________________________Studying as PG Scholar at 
National Institute of  Siddha, Tambaram Sanatorium is doing a trial on the study “KATTU 
MANTHAM”. I will maintain confidentiality of your comments and data obtained. There 
will be no risk of disclosing your identity and no physical, psychological or professional risk 
is involved by taking part in this study. Taking part in this study is voluntary. No 
compensation will be paid to you for taking part in this study. 
           You can choose not to take part. However, taking part in the study may be of benefit to 
the community, as it may help us to understand the problem of defaulters and potential 
solutions. 
             If you agree your child to be a participant in this study, he/she will be included in the 
study primarily by signing the consent form and then you will be given the internal medicine 
SEENTHIL KUDINEER[10ml-twice a day]. 
The information I am collecting in this study will remain between you and the 
principal investigator (myself).  
If you wish to find out more about this study before taking part, you can contact 
myself Dr.P.MIRUNALENI, PG Scholar 8122978302. You can also contact the Member-
secretary of Ethics committee, National Institute Siddha, Chennai 600047, Tel no : 91-44-
22380789, for rights and participation in the study.                                                                          
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
                        A CLINICAL EVALUATION OF SEENTHIL KUDINEER FOR 
KATTU MANTHAM IN CHILDREN. 
                                       FORM VII    WITHDRAWL FORM   
1. S.l. No: 2. OP/ IP No  : 3. Name: 
4. Age: 5. Gender: 6. Date of Enrollment: 
7. Date of completion: 8. Informant: 9. Reliablity: 
 
 
Date of trial commencement    : 
Date of withdrawal from trial   : 
Reason(s) for withdrawal   : Yes/ No  
Long absence at reporting   : Yes/ No 
Irregular treatment     : Yes/ No 
Shift of locality      : Yes/ No 
Complication adverse reactions if any : Yes/ No 
Exacerbation of symptoms   : Yes/ No 
 Patient not willing to continue             : Yes/ No 
 
Date:   Signature of Principal Investigator  
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
              A CLINICAL EVALUATION OF SEENTHIL KUDINEER FOR KATTU 
MANTHAM IN CHILDREN. 
FORM VIII-ADVERSE REACTION 
 
                                                  
1. S.l. No: 2. OP/ IP No  : 3. Name: 
4. Age: 5. Gender: 6. Date of Enrollment: 
7. Date of completion: 8. Informant: 9. Reliablity: 
 
 
Name       : 
Age       : 
Gender    : 
OPD/ IPD No    : 
Registration No    : 
Date of trial commencement  : 
Date of withdrawal from trial   : 
Description of adverse reaction  : 
 
 
Date:       Signature of Principal Investigator 
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1. Patient / consumer identification (please complete or tick boxes below as appropriate) 
NATIONAL PHARMACOVIGILANCE PROGRAMME FOR  SIDDHA DRUGS 
 
 
 
 
Please note:  i. All consumers / patients and reporters information will remain confidential. 
                        ii. It is requested to report all suspected reactions to the concerned, even                    
if it does not have complete data, as soon as possible. 
Peripheral Center code:     State:  
 
 
Name  Father name 
 
Patient / Record No. 
Ethnicity  Occupation 
Address  
Village / Town 
Post / Via 
District / State    
Date of Birth / Age: 
 
Sex:     Male / Female  
Weight : 
Degam: 
 
2. Description of the suspected Adverse Reactions (please complete boxes below) 
 
Date and time  of 
initial observation 
 Season: 
Description of 
reaction   
 
 Geographical area: 
Reporting Form for Suspected Adverse Reactions to Siddha Drugs 
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3. List of all medicines / Formulations including drugs of other systems used by the 
patient during the reporting period: 
 
Medicine Dail
y 
dose 
Route of 
administration 
& Vehicle – 
Adjuvant 
Date  Diagnosis for 
which medicine 
taken  
Starting Stopped 
Siddha 
 
 
 
 
     
Any other system 
of medicines 
 
 
     
 
4. Brief details of the Siddha Medicine which seems to be toxic : 
 
Details Drug – 1 Drug – 2 Drug - 3 
a) Name of the medicine    
b) Manufacturing unit and 
batch No. and date 
   
c) Expiry date    
d) Purchased and obtained 
from 
   
e) Composition of the 
formulation / Part of the drug 
used 
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b) Dietary Restrictions if any 
c) Whether the drug is consumed under Institutionally qualified medical supervision or used 
as self medication.  
d) Any other relevant information. 
 
5. Treatment provided for adverse reaction: 
 
6. The result  of the adverse reaction / side effect / untoward effects (please complete the 
boxes below) 
 
Recovered:           Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   No. Reaction abated after drug stopped or dose reduced: 
 
Reaction reappeared after re introduction: 
 
 
Was the patient admitted to hospital? If 
yes, give name and address of hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities?  If Yes specify:  
 
8. Whether the patient is suffering with any chronic disorders? 
Hepatic    Renal    Cardiac    Diabetes    Malnutrition    
 
Any Others  
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9. H/O previous allergies / Drug reactions:  
 
10. Other illness (please describe): 
 
11. Identification of the reporter: 
Type (please tick):  Nurse / Doctor / Pharmacist / Health worker / Patient / Attendant / 
Manufacturer /                                                                      
                                Distributor / Supplier / Any others (please specify) 
Name: 
 
Address: 
 
Telephone / E – mail if any : 
 
 
Signature of the reporter:       Date: 
 
Please send the completed form to:  
           The Director 
            National Institute of Siddha, 
                                                           (Pharmacovigilance Regional Centre For Siddha dicine), 
                                                           Tambaram Sanatorium, Chennai-600 047. 
                                                            (O) 044-22381314       Fax : 044 – 22381314 
        Website : www.nischennai.org  
        Email: nischennaisiddha@yahoo.co.in   
 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** * * * *  
Name & address of the RRC-
ASU / PPC-ASU 
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This filled-in ADR report may be sent within one month of observation /occurrence of 
ADR   
 
 
 
   
                                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Who Can Report?     
 Any Health care professionals like Siddha Doctors /  Nurses / Siddha 
Pharmacists / Patients etc.  
What to Report?  
 All reactions,  Drug interactions,  
Confidentiality  
 The patient’s identity will be held in strict confidence and protected to the 
fullest extent.  
 Submission of report will be taken up for remedial measures only not for 
legal claim  
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A CLINICAL EVALUATION OF SEENTHIL KUDINEER FOR KATTU                      
MANTHAM  IN CHILDREN 
 FORM IX-DIETARY ADVICE FORM 
 THINGS TO TAKE  THINGS TO AVOID 
Fruits-Fig,Papaya,Gauva,Grapes,Bananas, 
apples, orange,dates 
 
Refridged items 
 
All greens eg-palak Tin and canned  foods 
 
Fresh vegetable soups Cream containing biscuits and cakes 
 
Boiled water Junk and fast foods 
 
Fiber rich foods eg-whole-grain breads and 
cereals,almonds,legumes 
 
Use palm candy instead of white sugar 
 
White sugar 
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FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of 
Trial 
CTRI No 
CTRI/2016/04/006818 [Registered on: 12/04/2016] Trial 
Registered Retrospectively 
Acknowledgemen
t Number  
REF/2015/08/009557  
Last Modified On: 13/06/2016 
Post Graduate 
Thesis  
Yes  
Type of Trial  Interventional  
Type of Study   Siddha  
Study Design  Single Arm Trial  
Public Title of 
Study   
Clinical trail for dyspepsia in children  
Scientific Title of 
Study  
Clarification(s) with 
Reply  
Modification(s)   
CLINICAL EVALUATION OF SEENTHIL KUDINEER FOR KATTU 
MANTHAM (DYSPEPSIA) IN CHILDREN.  
Acronym    
Secondary IDs if 
Any   
Secondary ID  Identifier  
NIL  NIL  
  
Details of 
Principal 
Investigator or 
overall Trial 
Coordinator 
(multi-center 
study)  
Clarification(s) with 
Reply  
Modification(s)   
Name  Dr PMirunaleni  
Designation  PG Scholar  
Affliation  National Institute of Siddha  
Address  
National Institute of Siddha Tambaram sanatorium 
Chennai-47 
National Institute of Siddha Tambaram sanatorium 
Chennai-47 
Chennai 
TAMIL NADU 
600047 
India  
Phone  8122978302   
Fax     
Email  mirunalenibsms@gmail.com   
  
Details Contact 
Person 
Scientific Query  
Clarification(s) with 
Reply  
Name  Dr PMirunaleni  
Designation  PG Scholar  
Affliation  National Institute of Siddha  
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Modification(s)   
Address  
National Institute of Siddha Tambaram sanatorium 
Chennai-47 
National Institute of Siddha Tambaram sanatorium 
Chennai-47 
Chennai 
TAMIL NADU 
600047 
India  
Phone  8122978302   
Fax     
Email  mirunalenibsms@gmail.com   
  
Details Contact 
Person 
Public Query  
Clarification(s) with 
Reply  
Modification(s)   
Name  DrAAmalaHazel MDs   
Designation  Lecturer  
Affliation    
Address  
National Institute of Siddha Tambaram sanatorium 
Chennai-47  
 
Chennai 
TAMIL NADU 
600047 
India  
Phone  9486909809   
Fax     
Email  dramalaaruldhas@gmail.com   
  
Source of 
Monetary or 
Material Support   
Self  
  
Primary Sponsor   
Name  National Institute of Siddha   
Address  
National Institute of Siddha Tambaram 
sanatorium Chennai-47   
Type of 
Sponsor  
Research institution and hospital  
  
Details of 
Secondary 
Sponsor   
Name  Address  
NIL  NIL  
  
Countries of 
Recruitment   
  India   
Sites of Study  
Clarification(s) with 
Reply  
Modification(s)   
No of Sites = 1   
Name of 
Principal 
Investigator
  
Name of 
Site  
Site 
Address  
Phone/Fax/Email  
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Dr P 
Mirunaleni  
Ayothidas
s 
pandithar 
hospital  
Room No -9 
, 
Kuzhandhai 
maruthuva
m 
Department 
,Ayothidass 
pandithar 
hospital 
National 
Institute of 
Siddha 
Tambaram 
sanatorium 
Chennai 
Chennai 
TAMIL 
NADU  
8122978302 
 
mirunalenibsms@gmail.co
m  
  
Details of Ethics 
Committee  
Clarification(s) with 
Reply  
Modification(s)   
No of Ethics Committees= 1   
Name of 
Committee  
Approval 
Status  
Date of 
Approval  
Approval 
Document  
Is 
IEC?  
Institutional 
Ethics 
Committee  
Approved  26/08/2014  Approval File  No  
  
Regulatory 
Clearance Status 
from DCGI   
Status  Date  Aproval Document  
Not Applicable  No Date Specified  No File Uploaded  
  
Health Condition 
/ Problems 
Studied   
Health 
Type  
Condition  
Patients  
Constipation Indigestion Stomach Pain Cough Fever 
  
  
Intervention / 
Comparator 
Agent  
Clarification(s) with 
Reply  
Modification(s)   
Type  Name  Details  
Comparator 
Agent  
Nil  Nil  
Intervention  
Seenthil 
Kudineer  
Seenthil kudineer 10 ml BD 
orally for a day only   
  
Inclusion 
Criteria   
Age From  1.00 Year(s) 
Age To  3.00 Year(s) 
Gender  Both  
Details  
Indigestion 
Stomach Pain 
Cough 
Fever 
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Constipation  
  
Exclusion 
Criteria  
Details  
Irritable Bowel syndrome 
Childhood asthma 
Intolerable stomach pain  
  
Method of 
Generating 
Random 
Sequence   
  
Method of 
Concealment   
  
Blinding/Masking
   
  
Primary 
Outcome   
Outcome  TimePoints  
Relief from the symptoms  2 days  
  
Secondary 
Outcome   
Outcome  TimePoints  
any toxicity of the drug  14 days  
  
Target Sample 
Size   
Total Sample Size="40" 
Sample Size from India="40"  
Phase of Trial   Phase 2  
Date of First 
Enrollment 
(India)  
Clarification(s) with 
Reply  
Modification(s)   
15/09/2015  
Date of First 
Enrollment 
(Global)  
No Date Specified  
Estimated 
Duration of Trial   
Years="1" 
Months="0" 
Days="0"  
Recruitment 
Status of Trial 
(Global)  
Modification(s)   
Not Applicable  
Recruitment 
Status of Trial 
(India)  
Open to Recruitment  
Publication 
Details   
After the study  
Brief Summary   My trial drug contains Tinospora cardifolia  (seenthil 
116 
 
thandu), Araca catechu  (kali pakku), Operculina 
terpethum  (sivathai), Terminalia chebula (kadukkai), Zingiber 
officinalis (sukku),  Picrorhiza scrophulariiflora 
(kadukurokini), Aloe barbadence (katralai sarugu). it is given to 
children below 3 years orally twice a day in  decotion form for 
a day to releive constipation. 
  
 
 
Ingredients of   Seenthil Kudineer 
 
                  
Fig 1 Zingiber officinalis                                                      Fig 2  Picrorhiza scrophulariiflora 
 
                   
Fig 3   Araca catechu                                                              Fig 4  Tinospora cardifolia                                                                              
                        
Fig 5 - Terminalia chebula                                              Fig 6 - Aloe barbadence (katralai sarugu)                    
                
                                      
Fig 7 Operculina terpethum                                                       Fig 8  Seenthil kudineer 
 
